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The Escherichia coli vitamin B12 transporter BtuCD-F is a type II importer belonging to 
the ABC transporter superfamily. Available data suggest both exporters and type I 
importers in the ABC superfamily employ similar transport mechanism in which the 
transmembrane (TMDs) are open to cytoplasm in the resting state, and ATP binding 
induces a major conformational change resulting in opening of the TMDs instead to the 
periplasm. However, the crystal structures of BtuCD from E. coli and recent EPR 
spectroscopy studies indicate that this type II importer employs a substantially different 
mechanism in which the TMDs are open to the periplasm in the resting state and to the 
cytoplasm after ATP binding. We have developed robust methods to study the 
conformation and transport mechanism of BtuCD-F reconstituted into lipid bilayers using 
single molecule fluorescence resonance energy transfer (smFRET) measurements. 
Fluorescent probes have been introduced at a variety of diagnostic sites, enabling 
smFRET to be used to measure distance changes in different conformational states as 
well as to observe the transitions between these states in real time. These data suggest 
that thermal fluctuations enable the transporter to explore different functional 
conformational states in the absence of ATP or other ligands. They also suggest that the 
ATP-bound state is indeed open to the cytoplasm and ATP binding/hydrolysis increases 
the rate of transition between open and closed states. Efforts are currently underway to 
observe the transport of vitamin B12 through a single BtuCD-F oligomer in real-time. 
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 ABC transporters are fascinating molecular pumps that facilitate the 
unidirectional translocation of a large variety of molecules across cellular membranes. 
This year marks the tenth anniversary of the first full-length x-ray crystal structure of an 
ABC transporter, BtuCD [1], and it has been over 35 years since the first molecular 
identification of P-glycoprotein (ABCB1, MDR1) in 1986 [2]. A great deal of effort has 
been put towards understanding the structure and function of these biologically important 
active transporters. So far the structure of 11 unique full-length ABC transporters have 
been solved to atomic resolution, and a myriad of biochemical and biophysical evidence 
help us better understand the molecular mechanisms of these transporters. 
 Over the last two decades, fluorescence microscopy has become an indispensible 
tool in biological research. The high sensitivity and ease-of-use of this technique make it 
suitable for a variety of research areas such as fluorescence resonance energy transfer 
(FRET), fluorescence polarization (FP), and fluorescence activated cell sorting (FACS). 
More recently, single-molecule FRET has been extensively used to monitor the dynamics 
of macromolecules at the single molecule level in real-time. Therefore, the single-
molecule approach complements the inherently static nature of crystallographic structures.  
 My thesis work has been focused on the study of the molecular mechanism and 





1.1 ABC transporters 
 ATP binding cassette (ABC) transporters are ubiquitous cytoplasmic membrane 
transporters found in all three domains of life [3,4]. ABC transporters facilitate 
translocation of a large variety of solutes across physiological membranes against 
concentration gradients using the energy from ATP binding and hydrolysis. Many of 
these transporters carry out essential cellular processes, and malfunction of these 
transporters can have devastating consequences. ABC transporters make up one of the 
largest superfamilies of proteins and in many cases they are found in large numbers: 
about 5% of the E. coli genome encodes for ABC transporters and humans have 48 of 
them [5-7]. A canonical functional transporter is comprised of two transmembrane 
domains (TMDs), each of which consists of 5~10 TM helices, and two cytoplasmic 
nucleotide binding domains (NBDs), which form the engine of the protein and bind and 
hydrolyze ATP molecules. 
1.1.1 Classifications 
 Functionally, ABC transporters can be classified as either importers or exporters 
depending on the direction in which their substrate moves. As their name says, ABC 
exporters transport substrates out of the. These ABC exporters translocate a large variety 
of substrates including cholesterol, lipids, small molecules, as well as peptides. These 
transporters bind substrates directly from the cytoplasm or from the inner leaflet of the 
inner membrane if substrates are hydrophobic and partition into the membrane. Unlike 
exporters, ABC importers are found only in prokaryotic cells and require a cognate 
periplasmic substrate-binding protein (SBP) for efficient substrate transport. ABC 
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importers themselves do not bind substrates with sufficiently high affinity [8-11] and 
must depend on their cognate substrate-binding protein for substrate supply. 
 
Figure 1.1 Domain organization of ATP-binding cassette transporters. A minimal functional transporter 
comprises four domains: two transmembrane domains (TMDs) and two nucleotide-binding domains (NBDs). 
These four domains can be encoded by either as many as four separate polypeptides (Panel A) or as little 
as one long polypeptide (Panel F). Here the letters and colors indicate distinct polypeptides. Combinations 
shown here are not exhaustive and this figure was adopted from Lewis et al.[12]. 
 
1.1.2 Domain architecture 
 ABC transporters consist minimally of two TMDs and two cytoplasmic soluble 
NBDs. As shown in Figure 1.1, these four modules can be encoded by as many as four 
separate polypeptides or one very long polypeptide [4,7]. Bacterial importers are 
typically composed of four separate polypeptides (Panel A), whereas bacterial exporters 
are typically dimers of two half transporters, each of which has one TMD fused to a NBD 
(Panel D & E). The eukaryotic ABC exporters are either dimer of two half transporters or 
full transporters with all four domains fused together. 
1.1.2.1 Transmembrane domains (TMDs) 
 Sequence alignment of TMDs of ABC transporters shows very low sequence 
conservation of the region, and this diverse TMDs might reflect the vast array of 
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substrates that these transporters recognize [1,4,7,13,14]. Each TMD consists of 5-10 α–
helices, which cross the lipid bilayer and form a tight helix bundle. Together with the 
other TMD, they form a permeation pathway in their dimer interface. 
 Each TMD of ABC exporters comprises six transmembrane helices and protrudes 
~25 Å into the cytoplasm before making contacts with NBDs [15]. The regions between 
the TMDs and the NBDs are called the intracellular domains (ICD-1 and ICD-2), and are 
unique to ABC exporters. These two ICDs of each TMD make contact with both NBDs: 
ICD-1 interacts with the NBD of the same half transporter while the ICD-2 interacts with 
the NBD from the other half transporter [15-18]. 
 The TMDs of ABC importers consists of 5-10 transmembrane helices and form 
tight bundles that span just beyond the surface of the membrane bilayer. Based on the 
TMD architecture, importers are divided into two sub-classes: the type I importers and 
type II importers. The TMDs of type I importers contain 5~7 TM helices and these 
transporters are responsible for importing relatively small molecules such as methionine, 
maltose or molybdate. The TMDs of type II importers comprise up to 10 TM helices and 
these importers takes up much larger molecules (e.g., vitamin B12 and heme) compared 
with the type I importers. Unlike the TMDs of exporters, the TMDs of importers make 
contact with one NBD on the same half transporter and do not interact the NBD of the 
other monomer [1,19]. This difference in TMD-NBD domain interaction between 
exporters and type II importers suggests that they might employ different mechanisms of 




Figure 1.2 NBD sandwich dimer. Each NBD is comprised of an F1-type ATPase core subdomain (shown in 
gray) and an α–helical subdomain (shown in pink) that is unique to ABC transporters. The conserved motifs 
are shown in different colors: the Walker A (red), the Walker B (magenta), Q-loop (purple), and the ABC 
signature, LSGGQ (green). Two ATP molecules are bound at the dimer interface indicated by the dashed 
line. 
 
1.1.2.2 Cytoplasmic nucleotide-binding domains (NBDs) 
 Each NBD consists of an F1-type ATPase core subdomain and an ABC specific 
α–helical subdomain. As shown in Figure 1.2 the F1-type core subdomain (shown in 
gray) contains the Walker A, Walker B, and Q-lopp motifs found in other ATPases, and 
the α-helical subdomain (shown in pink) contains the conserved LSGGQ signature motif 
[20]. ATP binding is a cooperative activity between two NBDs arranged in a head to tail 
configuration; two ATP molecules bind at the interface of the NBDs (shown by the 
dashed line in Figure 1.2) and interact with the LSGGQ motif of one monomer and the 
Walker A motif of the other [20,21]. The conformational change upon ATP binding and 
subsequent closed NBD dimerization is transmitted to the TMDs via the coupling helices 
and induces conformational changes in the TMDs required for substrate transport [22]. 
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 The crystal structures of NBDs bound to ATP indicated closed dimers in a head-
to-tail configuration [20,21,23,24].  
1.2 ABC transporters in humans 
 Humans have 48 ABC transporters classified into 7 subfamilies (ABC-A to G) 
based on sequence similarity and domain organization. Table 1.1 contains a brief 
summary of these subfamilies. Defects in a number of these transporters (18 out of 48) 
are directly related to genetic disorders [5,25].  For example, cystic fibrosis is caused by a 
single phenylalanine deletion mutation (phenylalanine 508 deletion, ∆F508) in the cystic 
fibrosis transport regulator gene (CFTR) [26]; Tangier disease, characterized by impaired 
efflux of lipids, has a mutation in ABCA1 [27]; Adrenoleukodystrophy (ALD), 
characterized by deficient translocation of very long chain fatty acids (VLCFA) in myelin 
cells resulting in cell death and unshielded nerve cells, is caused by a mutation in the 
ABCD1 gene [28]. When exposed to cytotoxic molecules, cells mobilize defense 
mechanisms against the toxic compounds, and one of the mechanisms is overexpression 
of multi-drug resistant transporters (MDR) to clear the drugs.  This benevolent innate 
mechanism is seen as an obstacle in cancer treatment where over 50 percent of cancer 
cells overexpresses MDR transporters, which dramatically reduces the efficacy of 
chemotherapeutic reagents [29].   
Table 1.1. Seven subfamilies of human ABC transporters [5,25,30]. 
Name Family Members Function 
ABC1 ABCA 12 Cholesterol and lipid transport 
MDR ABCB 11 Peptides and bile transport 
MRP ABCC 13 Chloride ion transport (CFTR), toxin secretion 
ALD ABCD 4 Peroxisome ABC transporters 
OABP ABCE 1 No TMDs, RNase L inhibitor 
GCN20 ABCF 3 No TMDs, Regulate protein synthesis 
White ABCG 5  Transport lipids, drugs, bile, cholesterol 
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1.3 Bacterial ABC transporters 
 As much as 16% of the open reading frames in bacterial genomes has been 
predicted to encode membrane transporters, and a significant proportion of these are 
ABC transporters [31]. Bacterial exporters play important roles in maintaining bacterial 
physiology. The functions of these exporters are closely involved in essential bacterial 
cellular processes such as cell wall biogenesis, protein secretion, and xenobiotic or 
metabolic waste excretion [12]. 
 In addition to ABC exporters, bacteria also produce importers for the uptake of 
nutrients such as ion, amino acids, sugars, and vitamins from the environment. As we 
have seen, these importers utilize substrate-binding proteins for the supply of their 
substrate. This class of ABC transporters includes the E. coli vitamin B12 importer that is 
the model transporter studied throughout this thesis. 
 The insights that we gain from the structural and functional studies of bacterial 
ABC transporters will not only provide strategies to combat virulent bacterial pathogens, 
but also provide invaluable clues to better understand their eukaryotic molecular 
counterparts, which are generally much harder to study in vitro. 
1.4 High resolution structures of ABC transporters 
 Like many other membrane proteins, structural determination of ABC transporters 
is quite challenging. Starting with the first structure of BtuCD in 2002, the atomic 
structures of 11 distinct ABC transporters have been determined. These include two 
eukaryotic ABC transporters, a mouse P-glycoprotein [17] and a human mitochondrial 
ABC transporter [16] as shown in Table 1.2. In addition, a large number of structures of 
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isolated NBDs (either in monomers or in closed dimers) have been solved, which 
together with the full-length structures contributed to our understanding of the molecular 
mechanisms of ABC transporters. 
Table 1.2. List of atomic structures of ABC transporters with known 3D Structures.  
Protein PDB ID Reference 
Vitamin B12 transporter from E. coli (3.2Å) 
BtuCD-F complex (2.6Å) 




Locher et al (2002) [1] 
Hvorup et al. (2007) [9] 
Korkhov et al. (2012) [35] 
Sav1866 multidrug transporter: S. aureus (3.0Å) 2HYD Dawson et al. (2006) [15] 
Molybdate transporter ModBC complexed with ModA (3.1Å) 2ONK Hollenstein et al. (2007) [36] 
ModBC ABC transporter in a trans-inhibited state (3.0Å) 3D31 Gerber et al. (2008) [37] 
HI1470/71 putative metal-chelate-type ABC transporter (2.4Å) 2NQ2 Pinkett et al. (2007) [19] 
MsbA lipid flippase with bound AMPPNP (3.7Å) 
Open apo (5.3Å) 
Closed apo (5.5Å) 









P-glycoprotein from Mus musculus (3.8Å) 
With bound QZ59-RRR (4.4Å) 




Aller et al. (2009) [17] 
 
 
MalFGK2-MBP maltose uptake transporter (2.8Å) 
MalFGK2 uptake transporter (TM1 deleted) (4.5Å) 
MalFGK2-MBP complex, pre-translation state (3.1Å) 





Oldham et al. (2007) [23] 
Khare et al. (2009) [33] 
Oldham and Chen (2011) [32] 
Oldham and Chem (2011) [32] 
MetNI methionine uptake transporter (3.7Å) 3DHW Kadaba et al. (2008) [38] 
Heterodimeric ABC transporter TM287-TM288 (2.9Å) 3QF4 Hohl et al. (2012) [39] 
ABCB10 mitochondrial ABC transporter with AMPPC (2.85Å) 2YL4 Shintre et al (2012) [16] 
 
 The best example of these is provided by the structures of the maltose importer 
MalFGK2-E from E. coli captured at multiple transition states [23,32-34]. In the resting 
state, the substrate permeation channel of MalFGK2 is facing inward as shown in panel A 
of Figure 1.3. When substrate loaded MalE binds to MalFGK2, the TMDs undergo 
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conformational changes, which are transmitted to the NBDs. The NDBs move closer 
together and their binding affinities for ATP increase (panel B). Subsequent ATP binding 
and NBDs dimerization induce conformational changes in the TMDs and the channel 
faces outward with MalE still associated with MalFGK2 (panel C). The conformational 
states observed in the MalFGK2 crystal structures agree very well with the results from 
biochemical and biophysical studies. 
 With the exception of MalFGK2, complete pictures of the intricate molecular 
mechanisms of other transporters require further investigation.  
 As I will summarize in Chapter 4, I have carried out x-ray crystallography of a 
number of ABC transporters including BtuCD-F, the E. coli lipid flippase MsbA, and its 
homologs. Although this project has not yielded x-ray quality protein crystals, the use of 
epitope engineering has produced promising results. Thus, the epitope engineering 
approach will be tested more extensively to improve the crystallization propensity of 




Figure 1.3 Crystal structures of MalFGK2-E representing three distinct transition states. The figure is taken 
from Ref [32]. The Panel A shows the permeation pathway facing inward when the MalFGK2 is in the resting 
state. The transporter undergoes conformation changes when its cognate substrate-binding protein, MalE, 
binds and forms the complex as shown in the Panel B. The Panel C shows the structure with the permeation 
channel facing outward as NBDs bind ATP and form a closed dimer.  
 
1.5 Discoidal protein-lipid particles (nanodiscs) 
 Nanodiscs are nanometer-scale discoidal protein-lipid particles that provide a 
native-like membrane environment for in vitro studies of membrane proteins [40-43]. 
These nanodiscs are made of two copies of membrane scaffold protein (MSP) that 
encircle a small disk of phospholipid bilayer forming water-soluble membrane disks. 
MSPs are N-terminal truncated versions of human Apolipoprotein A-I, which is the 
major protein component of high-density lipoprotein (HDL) [42,43]. Various sizes are 
available, each of which gives unique disk dimensions ranging from 97~130Å in outer 
diameter. Unlike liposomes, nanodiscs form small homogeneous stable water-soluble 
particles, which enable the use of biochemical and biophysical techniques that are 
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normally reserved for soluble proteins to be applied to membrane proteins. Because of 
this versatility, all protein preparations used for this thesis study have been reconstituted 
into nanodiscs.  
1.6 Fluorescence resonance energy transfer (FRET) 
1.6.1 Ensemble FRET 
 Fluorescence resonance energy transfer (FRET) is a distance-dependent energy 
transfer between donor and acceptor fluorophores. The excited donor fluorophore 
transfers energy to the acceptor fluorophore through a non-radiative dipole-dipole 
interaction. FRET occurs when the emission spectrum of the donor fluorophore overlaps 
with the absorption spectrum of the acceptor fluorophore [44]. Energy transfer efficiency 
is inversely correlated to the sixth power of the distance separating the two fluorophores 
[45]. 
 FRET has been used widely to study molecular interactions. For example, with 
the fluorescent probe attached substrate-binding protein BtuF*, FRET to substrate B12 
has served as a molecular ruler to reveal B12 movement during the transport cycle. These 
FRET measurements have proven very useful in observing the movement of substrate 
through a membrane transporter in real-time [46,47].  
1.6.2 Single-molecule FRET 
 Over the last 15 years, single-molecule FRET has gained much popularity 
because this method enables one to extract an unprecedented amount of detailed 
molecular kinetics information [48-58]. Unlike traditional ensemble experiments where 
the observed fluorescence signal is the average over an ensemble of molecules making it 
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unable to detect molecular heterogeneity, with smFRET probes, individual molecules and 
sub-populations are readily observed. Several technological advances in recent years 
allow smFRET measurements to be applied to study protein folding [59,60], protein 
conformations and dynamics [49,51,57,61,62], and enzymatic reactions [50,56]. 
 Ensemble and smFRET measurements are therefore two of the major techniques 
used in my thesis work and I will provide further details on the use of both techniques in 
the appropriate chapters. 
1.7 Preview of the chapters in this thesis 
 The objective of my thesis project has been to understand the molecular 
mechanisms of ABC transporters, both functionally and structurally. In chapter 2, I have 
focused on elucidating the substrate movement through the transporter BtuCD during the 
transport cycle using FRET measurements. In chapter 3, I elucidated the TM domain 
conformational dynamics using smFRET measurements. And in chapter 4, I have 
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Reconstitution of BtuCD into nanodiscs and real-time observation of the 
vitamin B12 transport by fluorescence spectroscopy 
 
2.1 Introduction 
 First discovered from its relationship to the once fatal disease pernicious anemia, 
vitamin B12 (or cobalamin) is an essential cofactor. It is involved in metabolic reactions 
ranging from methyl transfers to DNA synthesis [1-3]. Biosynthesis of B12 involves a 
large number of enzymes, and only a limited number of bacteria and archaea have the 
complete repertoire of enzymes for its synthesis [1,2,4]. Humans must obtain vitamin 
B12 from their diet and are recommended to take ~2-5 µg/day [5]. Good dietary sources 
of vitamin B12 are animal foods including meat, milk, egg, fish, and shellfish. 
 Vitamin B12 is one of the most complex cofactors found in nature and because of 
this complexity passive diffusion through the biological membrane is very unlikely. Since 
only some bacteria and archaea can synthesize B12 de novo, all eukaryotes and those 
prokaryotes lacking the enzymes have developed import systems for B12 uptake from 
their environments [1,2,6,7]. In humans, the intrinsic factors released by parietal cells on 
the surface of the stomach scavenge B12 in the intestine and delivers it to cell surface 
receptors for uptake by endocytosis [6]. Pernicious anemia is an autoimmune disease in 
which the parietal cells of the stomach responsible for producing intrinsic factors are 
destroyed, resulting in an inability to absorb B12. The binding affinity of human intrinsic 
factor for B12 is ~0.1 nM, a value falling in the range of the affinities of active transport 
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systems found in enteric bacteria in the gut competing for the same scare resources 
[6,8,9]. 
 In E. coli, the cofactor B12 is used for methionine synthesis, ethanolamine 
utilization, and covalent modification of a tRNA base [7]. Because E. coli cannot 
synthesize B12, it expresses an import system for this cofactor. This chapter introduces 
the vitamin B12 import system in E. coli, emphasizing the molecular mechanisms of the 
inner membrane ABC transporter, BtuCD-F. Results are also presented from experiments 
using fluorescence resonance energy transfer measurements to monitor real-time B12 
movement through BtuCD.  
 
 
Figure 2.1 Structure of vitamin B12. (A) Shown here is 5’-deoxyadenosylcobalamin (Ado-B12, Mw=1580). 
The structure consists of three parts: a central corrin ring, an adenosyl moiety, and a nucleotide loop [2]. (B) 
A ball and stick model of Ado-B12. Carbon atoms are depicted in gray, nitrogen in blue, oxygen in red, 
phosphorus in orange, and cobalt in dark pink. 
 
2.1.1 Vitamin B12 uptake in E. coli 
 Vitamin B12 import in E. coli involves an array of proteins as schematically 
shown in Figure 2.2. At least three distinct groups of proteins are known to participate in 
the active transport of B12 into the cytoplasm of E. coli: an outer membrane receptor and 
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an inner membrane protein complex that interacts with this receptor, a periplasmic 
substrate-binding protein, and an inner membrane ABC transporter [6,8-12]. The outer 
membrane receptor, which is a beta-barrel protein containing 22 beta-strands, binds the 
substrate vitamin B12 with subnanomolar affinity and releases it to the periplasmic space 
using the energy of proton motive force [6,8,9,13]. The precise mechanisms of this B12 
release from the transporter require further experimental investigation, but it is thought 
that the C-terminal domain of the TonB component of TonB/ExbB/ExbD inner 
membrane protein complex interacts with the N-terminal region of BtuB to effect 
substrate release [10,14-17]. Once released into the periplasmic space, B12 is readily 
bound by the periplasmic substrate-binding protein (SBP), BtuF, and delivered to the 
inner-membrane ABC transporter, BtuCD, for its final passage into the cytoplasm 
[11,12,18-20]. Hereafter, I will only focus on the final stage of the B12 transport from the 
periplasmic space to the cytoplasm by BtuCD-F. 
 
Figure 2.2 Schematic diagrams of B12 import in E. coli.  Scheme on the left was taken from Krewulak and 
Vogel [21].  For simplicity, TonB and ExbB-D proteins were not drawn in the diagram on the right.  The outer 
membrane receptor, BtuB, binds B12 from the surrounding environments and transports it to the periplasmic 
space.  Once inside the periplasm, B12 is scavenged by the substrate binding protein, BtuF, which then 
delivers it to the inner membrane ABC transporter BtuCD.  BtuCD transports it to the cytoplasm using the 





2.1.2 Domain architecture of BtuCD-F 
 The inner-membrane transporter BtuCD is a member of ABC transporter 
superfamily and belongs to a class called type II importers. The transporter is comprised 
of two transmembrane domains (TMDs), each of which contains ten transmembrane 
helices that form the substrate permeation pathway at their interface, and two cytoplasmic 
nucleotide-binding domains (NBDs), which bind and hydrolyze ATP. As reviewed earlier 
in Chapter 1, the sequence conservation in TM domains among ABC transporters is very 
low, which seems likely to reflect their specificity for a diverse range of solutes that this 
family of transporters recognizes as substrates. The NBD of BtuCD contains all of the 
highly conserved motifs typical of NBDs from ABC transporters. Its F1-like sub-domain 
has the Walker A motif or P-loop (GxxGxGKS/T, where x is any amino acid), the 
Walker B motif (øøøD, where ø is a hydrophobic residue), and the Q-loop motif. Its 
alpha-helical sub-domain contains the ABC signature (LSGGQ, it is LSGGE in BtuCD) 
motif. Although no BtuCD structure was determined with bound ATP, it has been shown 
in other ABC protein structures, both in isolated NBD and in NBDs of complete 
transporters, that ATP binding is associated with NBDs forming a closed dimer in a head-
to-tail conformation with two ATP molecules bound at the dimer interface [22-26]. 
 BtuCD is a heterodimers, and each half comprises one transmembrane domain 
(BtuC) and a nucleotide-binding domain (BtuD). BtuCD itself cannot bind the B12 
substrate and receives it from the cognate substrate-binding protein, BtuF, as it was first 
shown by White el al. in 1973 [8]. 
2.1.3 BtuCD x-ray structures 
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 BtuCD is the first full-length ABC transporter whose atomic structure was solved 
by x-ray crystallography [19]. The first apo BtuCD structure (Figure 2.3A) was solved to 
3.2Å resolution and elucidated an architectural framework for complete transporters. The 
two TMDs are related by a two-fold rotation axis running roughly perpendicular to the 
membrane plane, and the NBDs are rotated by 25º with respect to the long axis of the 
BtuC dimer [19]. Compared to those of ABC exporters, the TMDs of ABC importers are 
much shorter and extend only slightly beyond the membrane surface. Each of the TMDs 
makes extensive contact with only its immediate NBD through the loop connecting TM6 
and TM7. This “L-loop” folds into two short helices, the second of which is also called a 
“coupling helix”, and this tight contact is thought to transmit conformational changes 
between the NBD and TMD [19].  
 
Figure 2.3 X-ray crystal structures of BtuCD and BtuCD-F complexes.  (A) Crystals of BtuCD alone grew in a 
solution containing 21% (w/v) PEG2000, 300 mM Mg(NO3)2, 0,8% 2-methyl-2,4-pentanediol, 100 mM Tris, 
pH 8.0. These crystals diffracted to 3.2 Å [19].  (B) Crystals of the BtuCD-F complex crystal grew in a 
solution containing 30~38% (w/v) PEG 400, 400 mM (NH4)2SO4, and either 50 mM Tris-HCl, pH 8.4. or 50 
mM Glycine-NaOH, pH 9.4. These crystals diffracted to 2.9 Å [27].  (C) Crystals of the complex of the 
E159Q mutant of BtuCD with BtuF grew in 30~35% (w/v) PEG400, 300~400 mM (NH4)2SO4, and 100 mM 
sodium citrate, pH 5.4. Crystals of the equivalent complex with selenomethionine-labeled BtuF grew in 
30~38% (w/v) PEG400, 400 mM (NH4)2SO4, and either 50 mM Tris-HCl, pH 8.4, or 50 mM Glycine-NaOH 
pH 9.4. These crystals diffracted to 3.5 Å [28]. 
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 The fact that one TMD makes contact only with its heterodimer partner NBD is 
unique to type II ABC importers, whereas each TMD of ABC exporters makes contact 
with both NBDs [24,29-31]. This architectural difference suggests that type II importers 
might employ different permeation channel opening mechanisms, but this inference 
requires further investigation. 
 As described above, the two NBDs in BtuCD form a dimer that is again related by 
a two-fold rotational symmetry around an axis roughly perpendicular to the membrane 
plane [19]. The exact mode of inter-domain interactions and the conformation of a dimer 
had been the subject of intense debate until the determination of this structure (partly 
fueled by an incorrect MsbA structure [32]). This BtuCD structure unambiguously 
showed that two NBDs form a dimer in a head-to-tail arrangement that was somewhat 
similar to that observed in the remotely related DNA repair enzyme, Rad50 [26]. Shortly 
thereafter, the crystal structure of the MJ0796 NBD bound to ATP showed an oligomeric 
organization even more similar to that of Rad50. [25] In these structures, two ATP 
molecules or two non-hydrolizable ATP analogs bind in the dimer interface, forming 
interactions with residues from the Walker A of one monomer and the ABC signature, 
LSGGQ, of the other monomer [19,25,26]. 
 Later, two structures of BtuCD complexed with BtuF were solved, providing 
more insight into the transport mechanisms of this transporter (Figure 2.3B&C) [27,28]. 
These two structures look very similar except for the orientation of the BtuF protein 
bound to BtuCD, which was rotated by 180º in one structure compare to the other. Their 
permeation channels were occluded, and no B12 was found in the permeation channel, 
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although the complexes were prepared in the presence of B12 [27,28]. The latest BtuCD-
F structure (PDB: 4LDB) was obtained with its catalytic base, glutamate-159 of NBDs, 
mutated to a glutamine with hopes to capture the ATP bound transition state, as had been 
done initially with the MJ0796 NBD [25]. Nonetheless, neither ATP nor non-
hydrolyzable ATP analogs were found at the interface [28].  
2.1.4 Proposed transport mechanism of BtuCD-F and type II importers 
 Available crystal structures and the results from both biochemical and biophysical 
studies suggest that the channel opening mechanism of BtuCD might be different from 
that of type I importers and ABC exporters [19,27,33-37]. Although minor differences 
exist, the direction of channel opening and the substrate release mechanisms of ABC 
exporters and type I importers appear to operate by a common four-step ATP switch 
model [38-40]. Step 1: the permeation channel of the transporter is open to the cytoplasm 
and the substrate binding (either from the cytoplasmic side or delivered by SBP from the 
periplasmic space) increases the transporters binding affinity for ATP. Step 2: the NBDs 
form a closed dimer and the resulting conformational change is transmitted to the TMDs 
causing the channel to open to the periplasm; exporters may release their substrates at this 
point. Step 3: ATP hydrolysis takes place, and this event triggers a conformational 
change in the TMDs that opens the channel again to the cytoplasm. Step 4: ADP and Pi 
are released from the transporter and the transporter cycles back to the initial resting state 
with its channel facing outward. However, with the exception of MalFGK2 structures, the 
other ABC transporter structures, including the BtuCD structures, cannot easily be 
assigned to their likely transition states during the functional transport cycle. For example, 
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two apo structures of the type II importers, HI1470/71 and BtuCD, respectively, are 
shown in Figure 2.4, with their permeation channels rendered as surfaces. Although they 
are both thought to represent an apo resting state, the directions of their permeation 
channels are open to opposite sides of the membrane [19,41].  
 Several lines of evidence suggest that BtuCD might operate by a mechanism 
distinct from that of ABC exporters and the type I importers. Although the structural 
discrepancy between two apo type II importers should be resolved, it is now thought that 
the channel of BtuCD in the resting state is facing outward [19,27,28,33,34,36,37] 
although the size of the opening is too small to accept B12 without further opening the 
gate. ATP binding and NBDs dimerization seems likely to induce channel opening to the 
cytoplasmic side [34,37]. 
 
Figure 2.4 Structural comparison between BtuCD and HI1470/71, a putative metal-chelate-type ABC 
transporter from Haemophilus influenza [41]. Accessible permeation pathways were generated with the 
program HOLE and depicted as surface blobs. In the resting state with no ATP bound, the transmembrane 
gate of HI1470/71 is partially open to the cytoplasmic side (panel A), whereas the gate of BtuCD is partially 




 Binding affinities for its cognate substrate and the substrate-binding protein 
makes this class of the type II importers different from the type I importers. For example, 
BtuCD and Hi1470/1471 bind the apo form of their cognate substrate-binding proteins 
with very high affinities (< ~1.0 nM), and the presence of substrates lowers the affinities 
[36] whereas the affinity of MalGFK2 for its cognate binding protein is the highest when 
the binding proteins are loaded with the substrate [42,43]. Also, neither BtuCD nor the 
BtuCD-F complex can bind B12 with sufficiently high affinity, so BtuCD must depend 
on its cognate substrate-binding protein, BtuF, for substrate supply [8,10,11,18]. 
2.1.5 Phospholipid bilayer disks (nanodiscs) as a vehicle for in vitro membrane 
protein studies 
 One of the first things to consider when studying membrane proteins in vitro is to 
properly shield the hydrophobic transmembrane regions of the proteins from water to 
prevent them from irreversible aggregation or precipitation. This goal can be achieved 
either in a simple way by solubilizing membrane proteins in detergent micelles or in a 
more complex way by reconstituting them into more natural lipid vesicles. Although 
widely used, the hydrophobic environments that detergent micelles provide are poor 
membrane-mimetics in some ways, and they often lack the vital properties necessary to 
keep the membrane proteins’ physiological activities. Membrane proteins in lipid-
vesicles (or liposomes) experience a more native-like environment, and the lateral 
strength of the lipid bilayer keeps the TM helices more stably associated with one another. 
A more recent technological development provides greater versatility in studying 
membrane proteins in a native-like environment in vitro. This technique uses discodial 
[CHAPTER)2)–)BTUCD)RECONSTITUTION)IN)NANODISCS]! 27 
 
protein-lipid particles, which are made of two copies of lipophilic α-helical protein that 
encircle a small disk of phospholipid bilayer [44,45]. These “nanodiscs” have been used 
successfully for experiments with a number of membrane proteins [46-54].  
 Like liposomes, nanodiscs provide a natural phospholipid bilayer environment for 
reconstituted proteins. More importantly, nanodiscs have a number of advantages over 
liposomes: the particle sizes are small, homogeneous, and they are water-soluble [55-57]. 
Because of these unique properties, biochemical and biophysical methods normally 
reserved for soluble proteins can now be used for membrane proteins reconstituted into 
nanodiscs. Therefore, all BtuCD proteins used in my thesis study were reconstituted into 
nanodiscs using E. coli lipid extracts. 
 
Figure 2.5 Fluorescence resonance energy transfer (FRET) and fluorescence anisotropy. (A-B) Schematic 
diagrams illustrating how spectral overlap (panel A) produces FRET, which is nonradiative energy transfer 
from an excited donor molecule to a suitable acceptor molecule. One example involves FRET from BtuF-
attached Alexa Fluor 546 to vitamin B12 (panel B), which results in quenching of the donor fluorescence but 
no acceptor fluorescence, because B12 is non-fluorescent.  (C) FRET efficiency (or the relative emission 
intensity) is inversely correlated to the distance to the sixth power. FRET is maximized when two molecules 
are in close proximity and minimized when they are far from each other. This phenomenon provides a 
molecular ruler to measure the relative distance between two molecules. (D) Fluorescence anisotropy 
measures the rate of molecular tumbling. As a molecule binds another molecule and forms a larger complex, 
the tumbling rate changes and anisotropy increases. 
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2.1.6 The substrate transport through BtuCD reconstituted into nanodiscs 
characterized by fluorescence resonance energy transfer (FRET) methods 
 These assays exploit methods developed by John Ramos, a former graduate 
student in the Hunt lab, to study vitamin B12 movement through BtuCD reconstituted 
into phospholipid bicelles [33,35]. He developed fluorescence spectroscopy methods that 
enabled substrate movement through ABC transporter to be monitored in real time, 
revealing unprecedented resolution of the transport mechanism [33,35]. These methods 
take advantage of the spectral properties of B12: its visible absorbance spectrum overlaps 
with the fluorescence emission spectrum of a number of commercially available 
fluorophores. Because of this spectral overlap (Figure 2.5A), FRET takes place between 
the fluorophore and B12 in a distance-dependent manner (Figure 2.5B & C). 
 The goal of the research reported in this chapter is to use the FRET methods 
schematized in Figure 2.5B–D to provide detailed insight into the substrate transport 
mechanisms of BtuCD-F reconstituted into native-like phospholipid bilayers in nanodiscs. 
The observed results and conclusions from these studies closely parallel those from 




2.2 Materials and Methods 
2.2.1 Protein Overexpression and Purification 
2.2.1.1 BtuF expression and purification 
 The BtuF expression plasmid was obtained from a former graduate student, John 
Ramos, and the mutant BtuF gene containing a cysteine at the C-terminal end (stop243C-
BtuF) was cut out and sub-cloned using NdeI and XhoI into a modified pET24a vector 
(EMD Millipore (Novagen), Billerica MA) in which its C-terminal His6-tag was replaced 
with sequences encoding a TEV protease cleavage site, a Flag-tag, and finally a His10-tag. 
Both the wild-type and the mutant BtuF were expressed in E. coli C43 (DE3) cells. Cells 
carrying the plasmid were grown at 37 ºC and 250 rpm in Terrific-Broth (TB) medium in 
a plastic Ultra Yield Flask (Ultra Yield Flask, Thomson Instrument, Oceanside, CA) 
supplemented with 50 µg/mL kanamycin and two drops of Antifoam (Antifoam 204, 
Sigma-Aldrich, St. Louis, MO). Cells were induced at an OD600 of ~0.6 with 1 mM IPTG, 
and protein expression was continued overnight at 25 ºC. Cells were then harvested by 
centrifugation, and each gram of wet weight in the pellet was resuspended in 5 mL of 
buffer containing 250 mM NaCl, 10 mM ß-mercaptoethanol (ßME), 50 mM Tris-HCl, 
pH 7.5 supplemented with 1 tablet of protease inhibitor cocktail (Roche) per 50 mL of 
cell resuspension. 
 The cells were lysed via 5~6 cycles of sonication (Qsonica, Newtown, CT) at an 
output amplitude of 60 (30 sec, 1 sec on, 1 sec off, 60 sec pause between cycles), and the 
resulting whole cell lysate was centrifuged at 20,000 g for 30 min. The supernatant was 
loaded onto a Ni-NTA column pre-equilibrated with 10 column volumes (CVs) of buffer 
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containing 250 mM NaCl, 1 mM ßME, 20 mM Tris-HCl, pH 7.5. After the supernatant 
passed through the resin, the column was washed with 10 CVs of the same buffer, 
followed by 10 CVs of the same buffer containing 25 mM imidazole. Finally, the bound 
BtuF was eluted in small aliquots of the same buffer containing 300 mM imidazole, 
which were collected in separate tubes. 
 After analyzing the elution fractions by SDS-PAGE, the fractions containing BtuF 
were pooled, and the C-terminal His10-tag was cleaved with TEV protease, while 
dialyzing the protein sample overnight at 4 ˚C against a large volume of 100 mM NaCl, 1 
mM Tris(2-carboxyethyl)phosphine (TCEP), 20 mM Tris, pH 7.0. The his6-tagged TEV 
protease used in this procedure was purified using standard methods [58]. The cleaved 
His10-tag and TEV protease were removed by running a second Ni-NTA column 
equilibrated with the dialysis buffer. The flow-through from this column was 
concentrated using a 10 kDa Amicon ultrafiltration device (EMD Millipore, Billerica, 
MA) to ~120 µM and stored in small aliquots at -80 ºC. 
2.2.1.2 BtuCD expression and purification 
 The BtuCD expression plasmid was originally obtained from the laboratory of Dr. 
Douglas Rees at California Institute of Technology. In this plasmid, BtuC and BtuD are 
co-expressed from a synthetic operon cloned into a single pET19b expression plasmid, 
which appends an N-terminal His10-tag to the transmembrane domain BtuC. E. coli C43 
(DE3) cells were transformed with this plasmid for protein overexpression. The cells 
were grown at 37 ºC in Terrific Broth containing 100 µg/mL ampicillin in an Ultra Yield 
Flask. When the OD600 reached 0.6, the growth temperature was reduced to 25 ºC and 
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protein expression was induced with 1 mM IPTG for 16~20 hours. The cells were 
harvested by centrifugation and washed once using a buffer containing 300 mM NaCl, 5 
mM ßME, 50 mM Tris-HCl, pH 7.5, and 1 tablet protease inhibitor cocktail per 50 mL. 
The resulting cell pellet was either lysed immediately to initiate purification or flash-
frozen in liquid nitrogen and stored at -80 ˚C pending purification at a later date. 
 Cell pellets were resuspended in 5 mL of the same buffer per gram of wet cell 
pellet and lysed either by three passages through an Emulsiflex-C3 (Avestin, Ottawa, 
Canada) or by sonication using a Sonicator 4000 (Qsonica, Newtown, CT). The whole 
cell lysate was centrifuged at 5000 g for 15 minutes, and the membrane vesicles in the 
resulting supernatant were collected by ultracentrifugation at >100,000g for 60 min 
(either at 26,000 rpm in an SW28 rotor or at 45,000 rpm in a Ti52 rotor, Beckman 
Coulter). The membrane pellet was resuspended in 25 mL of the same buffer containing 
1.5% (w/v) LDAO per gram of wet weight. After incubation overnight at 4 ºC with gentle 
rotation, un-solubilized materials were removed by ultracentrifugation at 100,000 g for 
60 min, and the resulting detergent extract was loaded onto a Ni-NTA column 
equilibrated in the same buffer containing 0.1% (w/v) LDAO. The column was washed 
with 10 CVs of the same buffer, followed by an additional ~5-7 CVs of the same buffer 
containing 50 mM imidazole. Finally, BtuCD was eluted with the same buffer containing 
300 mM imidazole. BtuCD-containing fractions were pooled and concentrated to ~10 
mg/mL using a 100 kDa Amicon ultrafiltration device, prior to purification on a 
Superdex-200-16/60 gel-filtration column (GE Healthcare, Piscataway, NJ) equilibrated 
in 0.1% (w/v) LDAO, 100 mM NaCl, 1 mM TCEP, 50 mM Tris-HCl, pH 7.5. The 
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BtuCD-containing fractions were pooled and concentrated to ~7 mg/mL prior to flash-
freezing in liquid N2 in small (~200-300 µL) aliquots and storage at -80 ºC pending use. 
2.2.1.3 Membrane Scaffold Protein (MSP1E3D1) expression and purification 
 The MSP proteins were expressed and purified as described by Bayburt et al. and 
Denisov et al. [45,57] with minor modifications. Expression plasmids pMSP1D1 [57] and 
pMSP1E3D1 [59] were purchased from Addgene (plasmid 20061 and 20066; Addgene, 
Cambridge MA). These genes were sub-cloned using NcoI and Hind III into the vector 
pET28, which also appends a TEV protease cleavable N-terminal His6-tag. 
 E. coli BL21 (DE3) cells carrying the expression plasmid were grown at 37 ºC in 
Terrific broth (TB) and protein expression was initiated via addition of 1.0 mM IPTG 
when the OD600 reached ~0.6. Protein expression was continued for 3~4 hours post 
induction, and cells were harvested by centrifugation. The cell pellet was resuspended in 
5 mL of buffer containing 1.0% Triton X-100 (Sigma-Aldrich), 1 mM 
Phenylmethylsulfonyl fluoride (PMSF, Thermo Scientific), 20 mM NaH2PO4, pH 7.4 per 
gram wet cell pellet and lysed using a probe sonicator (Qsonica).  Unbroken cells and 
inclusion bodies were removed by centrifugation at 5000 g for 10 min, and the cleared 
lysate was centrifuged at 30,000 g for 30 min. The resulting supernatant was loaded on a 
Ni-NTA affinity column equilibrated in 10 CVs of buffer containing 40 mM NaH2PO4, 
pH 7.4. The column was then washed with the following buffers: 1) 10 CVs of buffer A 
(300 mM NaCl, 40 mM Tris-HCl, pH 8.0) containing 1.0% Triton X-100, 2) 5 CVs of the 
same buffer A containing 50 mM sodium choate, , and 3) 7 CVs of the buffer A 
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containing 50 mM Imidazole. The bound MSP was eluted with buffer A containing 300 
mM Imidazole. MSP-containing fractions were pooled. 
 The N-terminal His6-tag was cleaved with TEV protease while dialyzing the 
protein sample against a larger volume of a nanodisc buffer (100 mM NaCl, 1 mM TCEP, 
0.01% NaN3, and 20 mM Tris-HCl). The His6-tag cleaved and TEV protease were 
removed by running a second Ni-NTA column equilibrated with the dialysis buffer. The 
flow-through from this column was collected and the column was washed with 2 CVs of 
the same nanodisc buffer containing 25 mM imidazole and collected on the same tube as 
the flow-through. This was then concentrated to ~3.7 mg/mL using a 10 kDa Amicon 
ultrafiltration device and stored at -80 ºC pending use. 
2.2.2 BtuF labeling with Alex Fluor 546 maleimide 
 The mutant BtuF with a cysteine residue engineered into the position right before 
the stop codon (stop243C-BtuF) was labeled with Alexa Fluor 546-C5-maleimide 
(AF546; Invitrogen, Grand Island NY) according to the manufacturer’s manual. The 
stop243C-BtuF mutant in 100 mM NaCl, 1 mM TCEP, 20 mM Tris-HCl, pH 7.0 was 
mixed with ~10-fold molar excess of AF546, and incubated at 25 ºC for ~2 hours. At the 
end of the incubation, 20 mM ßME was added to the reaction mixture to quench 
unreacted free dyes, and the labeled stop243C-BtuF (hereafter termed BtuF*) was 
purified by a Superdex-200-10/300 gel-filtration column. The fractions containing BtuF* 
were pooled and concentrated to ~3.0 mg/mL using a 10 kDa Amicon ultrafiltration 
device. Both protein and dye concentrations were determined spectrophotometrically. 
The protein concentration was calculated by the following equation: 
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 [!"#$] = ([!!"# − !!!"×0.12 ]×!") 47,450  (2.1) 
where 47,450 is the molar extinction coefficient of BtuF without theHis6-tag, 0.12 is a 
correction factor to account for the absorbance of the dye at 280 nm and dF is a dilution 
factor. And the concentration of Alexa Fluor 546 was calculated by the following 
equation: 
 [!"!"#] = [!!!" 104,000]×!"  (3.2) 
where 104,000 is the molar extinction coefficient in cm-1 M-1 of the Alexa Fluor 546 at 
554 nm. The labeling efficiency was then calculated by taking the ratio of the dye 
concentration over the protein concentration. 
2.2.3 BtuCD reconstitution into nanodiscs 
2.2.3.1 Detergent solubilized E. coli (total/polar) lipids for nanodisc formation 
 E. coli polar/total lipid extracts were purchased from Avanti Polar Lipids in 
chloroform at 20 mg/mL (100600C/100500C; Avanti Polar Lipids, Alabaster AL). Clear 
lipid film was prepared by drying lipids in chloroform overnight using a speedvac. The 
lipid-film was dissolved to a final concentration of ~40 mg/mL in the nanodisc buffer 
containing 100 mM sodium cholate (this is the lipid stock at approximately 50 mM). This 
lipid stock-solution was sonicated in a water bath sonicator (Branson) until a uniform and 
clear solution was obtained (3~4 times of 5 min sonication with vortexing in between). 
Freshly prepared lipid solution was subjected at least one round of freezing (in liquid 




2.2.3.2 Membrane protein reconstitution into discoidal protein-lipid particles 
(nanodiscs) 
 BtuCD reconstitution started by combining the detergent solubilized BtuCD, 
membrane scaffold protein (MSPE3D1) and detergent-destabilized lipid stock solution in 
the following ratios. For E. coli polar extract, molar ratios of 1:10 for MSP:lipids and a 
1:8 for BtuCD:MSP were used. This low BtuCD:MSP ratio ensures that each nanodisc 
complex receives only one BtuCD transporter. Following is an example with the final 
concentrations of 9.5 µM, 72 µM, and 8 mM for BtuCD, MSP, and lipids, respectively. 
 Once all the components were added in an eppendorf tube (total volume ~500 µL), 
the reaction mixture was incubated at 4 ºC for 1 hour with gentle rotation. After a one-
hour incubation, ~0.4-0.5 g Bio-Beads per 500 µL was added to the mixture to initiate 
detergent removal thereby initiating nanodisc formation. The detergent removal process 
was continued for another 4 hours (or overnight) at 4 ºC with gentle rotation. The sample 
was carefully recovered and filtered using a 0.22µm SpinX centrifuge tube filter (Corning, 
Tewksbury, MA) to remove the Bio-Beads and any aggregates. Finally, the nanodisc 
complex was purified by a Superdex-200-10/300 gel-filtration column equilibrated with 
the nanodisc buffer. Fractions containing nanodiscs were pooled and concentrated to 
~500 µL using a 100 kDa Amicon ultrafiltration device.  
 Bio-Beads SM-2 (Bio-Beads SM2, Bio-Rad, Hercules, CA) used in the process 
was prepared by washing it once with 10 volumes of methanol, once with 10 volumes of 
ethanol, and finally ten times with 10 volumes of MilliQ water [60]. Before use, 
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appropriate amounts were weighed after decanting water and directly added to the 
reaction mixture to initiate nanodisc formation. 
2.2.4 ATPase activity by calorimetric malachite green assay 
 ATPase activity was determined by a malachite green assay as described in [61] 
with a few modifications. The color reagents were prepared by mixing 0.045% malachite 
green hydrochloride (MG) and 4.2% ammonium molybdate in 4 N HCl (AM) in a 3:1 
ratio (v/v). 100 µL of 1.0% Triton X-100 (v/v) per 5mL was added to malachite green 
reagent solution, and the solution was filtered using a 0.22µm pore membrane StirFlip 
filter (EMD Millipore, Billerica, MA). ATPase activity of BtuCD in detergent and in 
nanodiscs was carried out in 500 µL reaction buffer containing 50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 5 mM MgCl2, and 1mM TCEP (0.1% LDAO was added to the buffer for 
BtuCD in detergent). ~60-100 nM BtuCD was incubated at 37 ºC for 2 min before the 
adding MgATP to initiate the reaction. Once MgATP was added, 50 µL aliquots were 
removed at various time points (5’, 10’, 20’, 30’, and 60’) and added to 800 µl malachite 
green color reagents, and incubated for 1 min. To this, 100µL of 34% sodium citrate was 
added to prevent non-enzymatic hydrolysis of ATP. The solutions were incubated for 
~20-30 min, then the amounts of inorganic phosphate at each time point were determined 
by taking the absorbance at 620 nm using a plate reader (150 µL per well, three replicas 
for each reaction). Malachite green reagents were calibrated for each experiment using 
KH2PO4 as a phosphate standard at various concentrations and this calibration was used 
in calculating the amount of Pi released as a result of ATP hydrolysis. Measured data 
were analyzed using a Prism 5.0a (GraphPad Software, La Jolla, CA). 
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2.2.5 BtuF binding affinity for B12 using Isothermal titration calorimetry (ITC) 
 The BtuF binding affinity for B12 was measured using an Auto ITC200 
(MicroCal, Piscataway NJ). 10 µM BtuF in a buffer containing 20mM Tris-HCl, pH 8.0, 
100mM NaCl, 1mM TCEP and 0.1% (w/v) detergents (Control, ß-DDM, C12E8, and 
LDAO) was loaded into the sample cell. B12 in the same buffer as BtuF was loaded into 
the injection syringe and titrated into the sample cell. A typical titration series involved 
19 injections of 2 µL of titrant (B12). The baseline was allowed to stabilize for 150 sec 
between injections to permit adequate time for reaction and equilibration. All 
experiments were performed at room temperature and the cell was stirred continuously at 
1000 rpm. For control experiments, the heats of dilution of B12 were measured in the 
absence of BtuF. The heat produced from each injection of B12 into BtuF or buffer was 
obtained by integration of the area under each peak of the titration plots with respect to 
time. Titration data (not corrected for the heat of dilutions) were analyzed with Microcal 
Origin using a single-site model (OriginLab Corp., Northampton, MA).  
2.2.6 Fluorescence resonance energy transfer (FRET) 
 T-format fluorescence measurements were performed at 25 ºC using a 
QuantaMaster C-61 spectrofluorimeter (PTI, Lawrenceville, NJ) equipped with dual 
photomultiplier detectors and Glan-Thompson polarizers. A 1.25 mL Suprasil 
fluorescence quartz cuvette (Hellma, Mullheim, Germany) was used to hold the sample 
and the sample was continuously mixed during all measurements using a magnetic stir 
bar. The fluorophore, Alexa Fluor 546, attached to the C-terminal end of BtuF* was 
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excited with a 520 nm excitation wavelength and the emission intensity at 570 nm was 
recorded. The total fluorescence was calculated as follows: 
 !! = !!! + 2!"!" (2-3) 
where!!!! is the fluorescence intensity recorded with excitation and emission polarization 
in the vertical position, and !!"  is the fluorescence intensity with the emission 
polarization aligned in with the horizontal position.  The G factor is the ratio of 
sensitivities of the detection system for vertically and horizontally polarized light and 
defined by the following equation: 
 ! = !!" !!! (2-4) 
the G factor was measured at the beginning of each experiment to use in the calculations. 
2.2.6.1 Fluorescence anisotropy 
 The steady state fluorescence anisotropy was calculated to measure the binding 
constants and kinetics of the reactions. And the fluorescence anisotropy was defined as 
 < ! >!= !!! − !"!" !!! + 2!"!" (2-5) 
In BtuCD-F binding experiments, following each injection, the signal was allowed to 
equilibrate and the mean anisotropy was calculated over the last 50 seconds. 
2.2.6.2 Curve-fitting methods for BtuF*-BtuCD binding analysis 
 Data were analyzed using the non-linear regression method of Marquardt and 
Levenberg as implemented in the program Prism 5.0a And the approaches were adopted 
from Ramos et al. [33]. Fluorescence anisotropy was fit to a standard form of the 




! = !! + (∆!!×!0.5!×!(1+ ( !! + [!!"!#$] !!!"!#$  
!!!!!!!!!!!!!!!!− ( !! + [!!"!#$])! [!"!"!#$]! + 2×( !! − [!!"!#$]) [!"!"!#$] + 1) (2.6) 
In this equation, S0 represents the measured signal in the absence of BtuCD, ∆S the 
change in the signal at full saturation, Kd the dissociation constant, [Ltotal] the total BtuCD 
concentration, and [sRtotal] the total concentration of active receptor molecules (here 
BtuF*). For determinations of binding affinity and stoichiometry of experiments 
conducted at several nominal concentrations of a BtuF*, all of these parameters were 
refined without restrains for each individual binding experiment, and the total BtuCD 
concentration at 50% saturation binding in that experiment was calculated as: 
 !!"!#$ 50%!!"#$%"#&'( = !! + !! [!"!"!#$] (2.7) 
These values were then plotted against [Rtotal-nominal], the total nominal BtuF* concentration 
and a linear regression was fit to determine the binding affinity and stoichiometry using 
the following equation: 
 !!"!#$ 50%!!"#$%"#&'( = !! + !! !!"!#$!!"#$!%&  (2.8) 
The standard error of the y-intercept from this regression on the ordinate was used as the 
estimated error of Kd, while the standard error of the slope from this regression was 





2.3 Results and Discussions 
2.3.1 Protein expression and purification 
 The purification protocols used in this study to purify individual protein 
component are shown schematically in Figure 2.6. Small-scale protein expression 
analyses showed that both BtuF and BtuCD were better expressed in E. coli C43 (DE3) 
cells than BL21 (DE3) cells, so C43 was the main expression host used in this study. The 
final cell density from cell cultures grown in the Ultra Yield Flasks in TB medium was so 
much higher than the cultures grown in a typical glass flask. The cell culture density at 
the end of protein expression typically reached OD600 >12.0 or wet cell weight of 20~25 
grams of from a liter culture). 
 
Figure 2.6 Outline of protein purification steps to purify protein used in this chapter. BtuF was purified by Ni-
NTA followed by TEV cleavage of His6-tag on the C-terminal. After labeling with AF546, the final labeled 
protein was purified by gel-filtration. After extracting from the membrane, BtuCD was purified by Ni-NTA and 





2.3.1.1 BtuF purification 
 As mentioned above, BtuF production was done in E. coli C43 (DE3) cells grown 
at 25ºC overnight in TB medium. BtuF contained His10-tag on the C-terminal and pure 
protein could be obtained from a single Ni-NTA affinity chromatography step.  
 BtuF is a periplasmic protein and contains a signal leader peptide (24 amino acids 
in BtuF). To verify whether the protein purified from the whole cell lysate has its leader 
peptide properly processed, the protein purified from the whole cell lysate was compared 
to the protein purified from the periplasmic component extracted by osmotic shock. 
Based on the SDS-PAGE analysis, two BtuFs purified by two different methods were 
identical. So BtuF used in the study was purified from whole cell lysate. 
 
Figure 2.7 The stop243C-BtuF mutant purification. Fractions from Ni-NTA affinity columns were analyzed by 
SDS-PAGE. (A) Affinity purification of stop243C-BtuF mutant. Elution 2 (lane 7) has over 90% pure 
stop243C-BtuF. (B) To remove the affinity tags, the protein sample was treated with TEV protease. After 
overnight TEV treatment, stop243C-BtuF without His10-tag was separated by Ni-NTA affinity column. Lane 
2 shows stop243C-BtuF before TEV, and the lane 3 shows after TEV treatment.  
 
 As it is shown in Figure 2.7A, large amount of pure BtuF (≥ 90% pure; ~30 mg 
protein from 1 liter culture) could be obtained from a single Ni-NTA affinity purification 
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(lane 7 in Figure 2.7A). BtuF-containing elution fractions were then mixed with TEV 
protease to cleave the C-terminal His10-tag. Tag removal was done while dialyzing the 
sample to reduce the imidazole concentration. The final protein was purified by running it 
through a second Ni-NTA column. Figure 2.7B shows the results before and after TEV 
treatment. The sample was concentrated and used in labeling with AF546-maliemide. 
2.3.1.2 BtuCD purification 
 The expression level of wild-type BtuCD was also much higher in E. coli C43 
(DE3) cells than in BL21 (DE3). The cell mass from 1 liter TB medium was 
approximately 25 grams using Ultra Yield Flasks. BtuCD extraction from the membrane 
fraction was performed with 1.5% LDAO. Like other proteins, detergent solubilized 
BtuCD was purified using a Ni-NTA column, and the results are shown in Figure 2.8A. 
The elution fractions indicated with dotted lines were pooled, and further purified by 
size-exclusion chromatography (Superdex-200-16/60). Pure mono-disperse BtuCD was 
eluted as a single peak at ~64 mL as shown in Figure 2.8B. The N-terminal of BtuC still 
contains His10-tag and this will be used when purifying nanodisc complex reconstituted 
with BtuCD from empty nanodiscs. The molecular weight of BtuCD in LDAO was 
determined by a Wyatt Static Light Scattering system connected to an AKTA purifier and 
the calculated molecular weight was ~228 kDa (BtuCD + detergent micelles). The final 
BtuCD was > 95% pure and the yield was ~1 mg from 1 gram initial wet cells (~25 mg 




Figure 2.8 BtuCD purification. (A) Fractions from a Ni-NTA column were analyzed by SDS-PAGE. Fractions 
between dotted lines were pooled and concentrated using a 100 kDa Amicon ultrafiltration device. This was 
then injected onto a size exclusion column to further purify and to do buffer exchange. BtuC is the upper 
band and the BtuD is the lower band. (B) Gel-filtration profile of BtuCD purified with 0.1% LDAO. Fractions 
within the dashed lines were pooled and concentrated using a 100 kDa Amicon ultrafiltrationi device. An 
approximate concentration was determined from the absorption at 280 nm. 
 
2.3.1.3 Membrane scaffold protein (MSP) purification 
 For overexpression and purification of MSP1E3D1, I have followed the published 
protocols. These proteins were expressed in E. coli BL21 (DE3) cells using TB medium 
supplemented with kanamycin [45,57]. The initial cell growth and short 3-hour protein 
induction was done at 37 ºC. The final cell mass from 1L culture medium was very little 
(2~3 grams of wet cells), and each preparation was done with cells from at least 4 liters 
of culture medium. MSP protein was > 90% pure after the first Ni-NTA affinity column 
and the His6-tag was removed the same way as BtuF (Figure 2.9A&B). The final protein 




Figure 2.9 Membrane scaffold protein (MSP) purification by Ni-NTA affinity columns. (A) Highly pure 
MSP1E3D1 was obtained from a single Ni-NTA column (lane 6 & 7 of panel A). (B) His6-tag was removed by 
TEV protease while dialyzing against larger volume buffer devoid of imidazole. MSP1E3D1 with His6-tag 
was purified by Ni-NTA (lane 3 & 4 contain the properly cleaved protein). 
 
2.3.2 Fluorescent labeling of BtuF 
 Fluorescent dye was prepared by dissolving small amount of reagent in Dimethyl 
sulfoxide solution (DMSO, Sigma Aldrich). To label BtuF, ~5-10 molar excess of 
fluorescent dye in DMSO was added to the protein solution. The reaction mixture was 
incubated at room temperature for 2 hours. The labeling was stopped with an addition of 
20 mM ßME followed by a PD-10 desalting column to remove excess free dyes prior to 
purifying in a gel-filtration column. After filtering the sample, labeled protein was 
purified by a Superdex200-10/300 gel-filtration column equilibrated with buffer 
containing 20 mM Tris pH 7.0, 100 mM NaCl, and 1mM TCEP. 
 Both the protein concentration and the labeling efficiency were calculated 
spectroscopically as described in the methods. Labeling efficiencies were typically > 80%, 
and ~40 µM (final concentration adjusted by the labeling efficiency) final stock solutions 
were stored in small aliquots. 
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Table 2.1 Phospholipids per leaflet, lipid transition temperature, and disc and bilayer diameters 
[51,56,62] 
MSP type Phospholipid (Tm) Diameters (Å) 


























2.3.3 BtuCD reconstitution into nanodiscs 
 As it is shown in Table 2.1, membrane protein reconstitution into nanodiscs using 
synthetic lipids (Avanti Polar Lipids, Alabaster, AL) has been well established over the 
last ten years [45,51,56,57,62,63]. Thus, BtuCD reconstitution was initially carried out 
with a synthetic lipid, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) using 
MSP1E3D1. A few test reconstitution runs accurately reproduced the MSP to lipid ratios 
stated in Table 2.1 (about 1 to 150 for MSP1E3D1 to DMPC produced a single peak, the 
blue gel-filtration trace in Figure 2.11A). The efficiency of reconstitution was roughly 
estimated by comparing the concentration of BtuCD before and after reconstitution, and 
typically it was greater than 50%. 
 The integrity of BtuCD in nanodiscs (using DMPC) was tested by ATPase 
activity. However, it turned out that BtuCD in nanodiscs made with DMPC could not 
hydrolyze ATP and showed no sign of substrate-induced stimulation. DMPC did not 
seem to be a suitable lipid for BtuCD because transporters may require a significant 





Figure 2.10 BtuCD reconstitution into nanodiscs. Purified BtuCD and MSP are mixed with detergent-
solubilized E. coli lipids and incubated in an orbital rotator at 4 oC. Reconstitution is initiated by removing 
detergent molecules with wet Bio-Beads. Once reaction is completed, the Bio-Beads are removed by 
filtration and nanodisc complexes are purified by SEC column. BtuCD but not other proteins contains his-tag, 
nanodisc/BtuCD complexes are further separated by Ni-NTA affinity column. 
 
 In fact, E. coli membranes (both inner and outer membranes) are devoid of 
phosphocholine and are mainly composed of three phospholipids: 
phosphatidylethanolamine (PE, ~63%), phophatidylglycerol (PG, ~23%), and cardiolipin 
(CA, ~10%) [64]. It was possible that the lipid bilayer BtuCD was in might have not been 
an optimal environment and BtuCD lost its activity. Therefore the next reconstitution was 





Figure 2.11 BtuCD reconstitution and complex purification. (A) Size exclusion chromatogram (Superdex 200 
10/300 column, GE healthcare). Black trace is for MSP, blue is for empty nanodiscs, and red trace is for the 
BtuCD-nanodisc complex. The peak positions for both empty nanodiscs and the BtuCD-nanodisc complexes 
are similar. (B) Fractions were pooled and analyzed by SDS-PAGE. Lane 1 is a molecular marker, lane 2 is 
a pooled sample, lane 3 is the same sample as lane 2 but after removing most empty nanodiscs via a Ni-
NTA affinity column. 
 
 Although the physical dimensions of BtuCD and nanodiscs would allow only one 
BtuCD per nanodisc, the BtuCD to MSP ratio was kept low to ensure no nanodisc 
received more than one BtuCD (typically a 1:8 BtuCD:MSP ratio was used). After a few 
rounds of optimization, BtuCD was successfully reconstituted into nanodiscs using E. 
coli polar lipids as shown in Figure 2.11A (red trace). The peak contained all three 
protein components, BtuC, BtuD, and MSP, as shown in Figure 2.11B (lane 2 & 3). 
Excessive amounts of MSP were shown in lane 2 of Figure 2.11B confirming that the 
peak consisted largely of empty nanodiscs, which was then removed by a Ni-NTA 
column. Once reconstituted, BtuCD behaved like a soluble protein: it no longer required 
added detergents in the buffer, and was stable even after repeated cycles of freeze and 
thaw. BtuCD concentration in nanodiscs was estimated from a scanned image of SDS-
PAGE using ImageJ (NIH, Bethesda, MD) [65]. The band intensity of BtuCD in 
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nanodiscs was compared to the bands from BtuCD at known concentrations. The final 
concentration in nanodiscs were typically 3~5 µM (full transporter). 
 The protein mono-dispersity of BtuCD in nanodiscs and the molecular weight 
were analyzed using a Dynamic Light Scattering, and a single peak at Mw of ~308kDa 
was observed. 
2.3.4 ATPase activities of BtuCD in detergent micelles and nanodiscs 
 Prior to the mechanistic analysis of BtuCD by FRET measurements, the 
integrities of BtuCD either reconstituted solubilized in detergent micelles was assessed 
by ATPase activity assay. The ATPase rates of both BtuCD in nanodiscs and in detergent 
micelles were determined by a malachite-green assay [61] as described in the methods, 
and the values were compared. The rates from detergent micelles and nanodiscs were 
plotted side by side and their rates were also compared to the results by Borths et al. as 
shown in Figure 2.12A & B [66]. BtuCDs in both environments exhibited typical high 
futile ATPase activities, and BtuCD in nanodiscs showed a moderate stimulation when 
substrate-loaded BtuF was added whereas no stimulation was observed for BtuCD in 
detergent micelles. 
 The thermodynamically futile so-called “basal ATPase activity” represents energy 
consumption in the absence of transport substrate. This futile ATP hydrolysis is, however, 
not necessarily mechanistically futile, but it could be rather an intrinsic property of many 
ABC transporters as suggested by Al-Shawi et al. [67] and Ernst et al. [68]. These 
transporters are intrinsically dynamic in solution instead of being trapped in a single 
energy minimum conformational state, and are pre-sampling states that occur during 
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substrate transport cycle [69]. Therefore, basal ATPase activity can be the direct result of 
a transporter sampling possible conformational states even in the absence of transport 
substrate. 
 Because basal ATP hydrolysis increases the rate of conformational sampling, it 
can enhance the probability of a transporter being in the right conformational state poised 
to accommodate transport substrate. ATP hydrolysis dissociates NBDs, resets the TMDs 
to the resting conformational state, and induces dissociation of the substrate binding 
protein BtuF from otherwise very stable BtuCD-F complex, which can enable BtuF 
scavenge available substrate molecules. 
 The basal ATPase rate of BtuCD in LDAO is extremely high (~130 
ATP/min/BtuCD) even in the absence of BtuF, and no stimulation by B12 substrate was 
observed. These results were almost indistinguishable to the values reported by Borths et 
al. [66], and these high basal ATPase rates suggested that the thermodynamic integrity of 
BtuCD was seriously compromised in detergent micelles, because even a scavenging 
function is impossible in the absence of BtuF. 
 The basal activity of BtuCD reconstituted into nanodiscs decreased by a factor of 
6.0 compared to that in detergent micelles indicating BtuCD in nanodiscs undergoes 
substantially less futile cycling. Moreover, addition of substrate-loaded BtuF induced a 
significant rate increases (~1.5-2.0 fold) that is in reasonable agreement with the data 
available in the literature [34,36,66]. Vitamin B12 alone did not stimulate the activity 
(pink bar in Figure 2.12D). However, apo-BtuF stimulated the activity as strongly as 
substrate-loaded BtuF (cyan and green bars in Figure 2.12D). One possibility is that this 
[CHAPTER)2)–)BTUCD)RECONSTITUTION)IN)NANODISCS]! 50 
 
stimulatory effect of apo-BtuF could be due to the co-purification of endogenous 
substrate B12 with BtuF, while another is that ATP hydrolysis could be promoting 
scavenging of B12. 
 
Figure 2.12 ATPase activities of BtuCD in LDAO vs. nandodiscs. (A) This is the result from Borths el at.[66] 
where the authors measured ATPase rates of BtuCD in various detergent conditions. Here the numbers 
indicate the concentrations of BtuF in µM, and +/- indicate the presence or absence of 50 µM B12. (B) 
ATPase rates are compared for BtuCD in LDAO vs. BtuCD in nanodiscs. BtuCD in LDAO had a very high 
basal ATPase activity in the absence of stimulation by the addition of B12-loaded BtuF. The basal activity 
was much lower for the BtuCD in nanodiscs and the activity increased by ~1.5-2.0 fold when B12-loaded 
BtuF was added (here the units are in (nmol/min/mg BtuCD) for easier comparison with the values from 
Borths et al. [66]). (C) Vmax of apo wild-type BtuCD reconstituted in nanodiscs. The calculated Km from the 
data by curve-fitting was 370 µM. (D) ~1.5-2.0 fold stimulation by B12-loaded BtuF. 
 
 High basal ATPase rates are not uncommon among ABC transporters. At one end 
of the spectrum there are ABC transporters like HisQMP from Salmonella typhimurium, 
OpuA from Lactococcus lactis, and MalFGK2 from E. coli that show sufficient ATPase 
rates only when supplied with cognate substrate binding proteins loaded with substrates 
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[70-72]. In contrast, BtuCD and the methionine transporter MetNI from E. coli exhibit 
high basal ATPase activities even in the absence of their cognate substrates [33,36,66,73]. 
Whether these large variations of the rates observed in vitro studies reflect the inherently 
different transport mechanisms among different ABC transporters are yet to be 
determined. 
 One possibility is that the basal activity of BtuCD could be regulated by other 
mechanisms and it functions only when necessary to transport B12. Another possibility 
could be inferred from classic B12 transport studies [6,8] where the authors carefully 
quantified the number of B12 binding sites per E. coli cell and B12 uptake rates. The 
results were that each cell had 200~1000 outer membrane receptors, with ~2 binding 
proteins in the periplasmic space. Each E. coli cell could import B12 molecules at a rate 
of 1~2 molecules/sec. If these numbers are correct, then each E. coli cell might have only 
a few copies of BtuCD (and also ButF) and energy consumption from even high basal 
ATPase activity might be negligible. However this again requires further study in the 
future for verification.  
2.3.5 The effect of the mutation on the ABC signature motif, LSGGE, E131Q, on 
its basal ATPase activity 
 Close inspection of the sequence alignment showed that BtuCD sequences in the 
highly conserved motifs in the NBDs deviated slightly from more canonical sequences. 
For example, its sequence at the ABC signature motif is LSGGE instead of LSGGQ as 
highlighted with red box in Figure 2.13. ABC dimer structures showed that this glutamate 
or glutamine interacts with the ribose moiety of ATP molecules bound at the dimer 
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interface [23,25,26]. The conserved serine and two glycine residues form hydrogen bonds 
with the oxygen atom on the γ-phosphate of bound ATP [23,25,26], and are involved in 
the ATP hydrolysis [74-76]. However, not much is known about the role of the glutamate 
at this position regarding the rate of ATP hydrolysis, and it was interesting to see what 
effect it had. Thus, in order to see if this sequence variation had any effects on the 
ATPase activities, I have generated a mutant where the glutamate in the LSGGE was 
replaced with glutamine (E131Q-BtuCD). This E131Q-BtuCD mutant was expressed in 
the same way as the wild-type BtuCD. The protein was expressed stably and in good 
quantity.  
 
Figure 2.13 Sequence alignment of BtuD showing the ABC signature motif. The last residue in the motif is 
glutamic acid in BtuCD whereas it is glutamine in more canonical sequence. 
 
 After reconstituting E131Q-BtuCD into nanodiscs, the ATPase activity was 
measured with and without substrate and BtuF by malachite green assay and the results 
are shown in Figure 2.14B (the same y scale as the wild-type was used for easier 
comparison). The results were quite unexpected. The basal rate was reduced substantially 
compared to that of wild-type BtuCD (~10 fold reduction, ~2.2 vs. 22.0 for E131Q-
BtuCD and wild-type BtuCD, respectively). As shown in wild-type BtuCD, BtuF alone 
stimulated the activity by a factor of ~2.0. However, the rate increase was much more 
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pronounced when 5 µM B12 and BtuF were added together (~8 fold increase compared 
to ~1.5 fold in wild-type). 
 Both the reduced futile ATPase activity and the greatly increased substrate-
induced activity of E131Q-BtuCD imply that this mutant is thermodynamically much 
more tightly coupled. The conformational changes of ATP hydrolysis is more effectively 
translated to productive substrate transport when compared to wild-type BtuCD. 
 
Figure 2.14 Effect of E131Q mutation on basal ATPase activities. The glutamic acid at position 131 in the 
ABC signature motif is mutated to glutamine. (A) Wild-type BtuCD with and without substrate and BtuF and 
(B) BtuCD-E131Q mutant in the absence and presence of the substrate and BtuF. 
 
2.3.6 Substrate binding affinity of BtuF in the presence of various detergents 
 The effect of detergent molecules on the activity of membrane proteins is rather 
well known (less than optimal regulation of activity and detergent molecules competing 
with the substrate for binding sites). However, what is less known is whether these same 
detergent molecules have any effects on the soluble proteins. 
 The ATPase rates of BtuCD in LDAO or ß-DDM alluded that the presence of a 
particular detergent in a reaction mixture might produce unexpected results. Although 
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BtuCD in both detergents showed elevated basal ATPase activities, BtuCD in ß-DDM 
showed a similar rate of substrate-induced stimulation when B12 and BtuF were added to 
the mixture. In contrast, the rates of BtuCD in LDAO showed no difference between the 
absence and presence of B12 and BtuF. In order to find out whether LDAO had anything 
to do with the BtuF binding affinity for B12, I have performed a binding experiment 
using an isothermal titration calorimetry (ITC) assay. Three commonly used detergents 
were tested for their effects on BtuF binding affinity for B12 along with a control with no 
detergent and the results are shown in Figure 2.15. The result with no detergent is shown 
in Figure 2.15A and BtuF bound B12 with an affinity that agreed well with the previously 
reported value of 15 nM [10]. Except for slight upshifts in the binding stoichiometry, the 
overall binding affinity in ß-DDM or C12E8 resembled that of no detergent. However, 
the presence of LDAO in the reaction buffer produced a completely different result: BtuF 
failed to bind B12 as indicated in Figure 2.15D.  
 
Figure 2.15 The detergent LDAO interferes with BtuF binding for vitamin B12. (A) binding with no detergent. 
(B) with 0.05% ß-DDM, (C) with 0.05% C12E8. (D) with 0.1% LDAO.  The top halves of the graphs show the 
specific heats released by each titration of CN-Cbl into purified BtuF-Cys267. The bottom halves show the 
enthalpies per mole of CN-Cbl injected versus the molar ratio (CN-Cbl/BtuF).  Notice the scale in (D), the 
change of enthalpy in this condition is comparable to that of the negative control (the heat of dilution of CN-




 Often, LDAO has been the first choice of detergent when measuring in vitro 
ATPase activities of BtuCD in a detergent environment. Complete blockage of B12 
binding to BtuF explains why BtuCD had no substrate-induced stimulation. Neither 
BtuCD nor BtuCD-F complex can bind B12 [8,33,36,77], and BtuF must bind B12 and 
deliver it to BtuCD to complete the uptake process. 
2.3.7 Real-time observation of the substrate transport 
 Using nanodiscs reconstituted with BtuCD, vitamin B12 transport was observed 
by monitoring both total fluorescence intensity and fluorescence anisotropy of BtuF* in 
real time. The assay was developed in the Hunt Lab where a former graduate student 
studied the B12 transport cycle using BtuCD reconstituted in lipid bicelles [33,35]. 
Overall, the results of these experiments agreed well with the previous results from 
BtuCD in bicelles. Each experiment started with BtuF* in the cuvette. B12 addition 
resulted in strong quenching of the total fluorescence of the BtuF* due to FRET to B12 
(Figure 2.16, the phase II). Addition of BtuCD in nanodiscs produced an immediate 
increase of anisotropy indicating fast binding of B12-loaded BtuF* to BtuCD (the early 
part of the phase III). This fast binding was followed by a slow de-quenching of BtuF* 
(!!/! ~2 min) reflecting the movement of B12 away from BtuF*. The total fluorescence 
at the end of the phase III returned to the initial level and FRET to B12 was completely 
eliminated. Then, addition of ATP caused BtuF* dissociation as indicated by a partial 
decrease of anisotropy as well as re-quenching of fluorescence as dissociated BtuF* re-
bound B12 (the phase IV). And this steady-state turnover continued until ATP was 
depleted (the depletion point is not shown in Figure 2.16). At the end of the experiment, 
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an excess of unlabeled BtuF (~25-fold molar excess) was added resulting in competitive 
displacement of BtuF* from BtuCD and depletion of B12 thereby leaving BtuF* free of 
B12. These were indicated by complete de-quenching of BtuF* and a simultaneous 
decrease of anisotropy in phase V. 
 
Figure 2.16 Monitoring vitamin B12 transport through the BtuCD-F reconstituted into nanodiscs in real-time. 
(I) Transport cycle starts with labeled BtuF* in the cuvette. (II) B12 is added to the cuvette and quenches 
fluorescence signal as it binds BtuF*. (III) BtuCD reconstituted into nanodiscs is then added and the 
fluorescence signal gets de-quenched as a result of B12 moving away from BtuF*. Fluorescence anisotropy 
indicates the formation of BtuCD-F complex. (IV) ATP binding and hydrolysis releases BtuF* which binds 
B12 and the fluorescence signal gets re-quenched. Steady state transport continues. (V) Chase BtuF* 
dissociation with excess amount of non-labeled BtuF. Non-labeled BtuF binds and depletes B12 leaving 
labeled BtuF* free from B12. 
 
 There are at least two questions that need to be addressed for a better 
understanding of the transport mechanisms: how is B12 released and how does BtuF 
dissociate from BtuCD. Following the initial fast binding of BtuF to BtuCD, B12 moves 
away from BtuF as indicated by a corresponding increase of total fluorescence intensity 
in the absence of nucleotides, implying that B12 is released from the complex. This, 
however, did not rule out the possibility that B12 was still bound in BtuCD, but far 
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enough from BtuF* and complete release is required for nucleotide binding and 
hydrolysis. The second question relates to what powers BtuF dissociation from BtuCD. 
Was it ATP binding and dimerization of NBDs that displaced BtuF or was it ATP 
hydrolysis? The answer to the first question could be found in a study by Lewinson et al. 
shown in Figure 2.17 [36]. The second question was addressed by Ramos et al. [33,35], 
and here I have generated an ATP hydrolysis deficient mutant and performed a transport 
experiment using this mutant in nanodiscs to see whether the results agreed with the 
previous findings. 
2.3.7.1 Substrate is released from the BtuCD-F complex in the absence of 
nucleotide 
 Deciphering whether B12 has been released or has remained trapped in the 
BtuCD transporter was addressed by the following simple experiments described by 
Lewinson et al. [36]. Gel filtration traces from B12-loaded BtuF and BtuCD-F complexes 
are shown in Figure 2.17. Panel A shows traces of B12-loaded BtuF alone, monitoring 
the absorbance maximum of B12 at 360 nm. B12-loaded BtuF was injected 1) without 
removing free B12 (blue trace), 2) after washing with 10X volume excess of buffer 
without B12 (red trace), and 3) finally after washing the sample with 100X volume 
excess of buffer devoid of B12 (black trace). Bound B12 remained bound in all three 
cases indicated by similar levels at the first peak (BtuF) whereas washing gradually 
eliminated the peak corresponding to the free B12 at ~20.5 mL (much reduced black 
peak). The traces in panel B are from BtuCD-F complexes where B12-loaded BtuF (after 
washing with 100X volume excess of buffer devoid of B12) was mixed with BtuCD at 
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various proportions. As the ratio of BtuCD:BtuF increased, the peak corresponding to 
free B12 increased proportionally indicating BtuCD-F complex formation resulted in B12 
release in the absence of any nucleotides. At a 2:1 BtuCD:BtuF ratio, almost all of the 
bound B12 was released from the complex, indicated by the complete disappearance of 
the peak at BtuF (doted-cyan trace). The peak increase at ~14 mL was due to small 
absorbance of BtuCD and BtuCD-F complex at the wavelength (high concentration 
BtuCD injected alone had the highest peak at the position shown by gray trace). 
 
Figure 2.17 B12 releases from BtuCD-F complex in the absence of nucleotide (figure taken from [36]). Gel 
filtration traces monitored the presence of B12 at its absorbance maximum at 360 nm. (A) Traces of B12-
loaded BtuF before and after removing free B12 from the sample. (B) B12-loaded BtuF devoid of free B12 
was then mixed BtuCD at various proportions and monitored the release of B12 in the absence of 




 This result confirms that the fluorescence de-quenching in Figure 2.16 reflects 
B12 release from the BtuCD transporter. Although at a slow rate, binding of substrate-
loaded BtuF was sufficient to induce conformational changes to BtuCD and B12 was 
transported through the permeation channel into the other side of the transporter (the 
cytoplasmic side). 
2.3.7.2 ATP hydrolysis is required for dissociation of BtuF from BtuCD 
 As it was shown before, I have exploited a mutant deficient in ATP hydrolysis to 
show that it is ATP hydrolysis that ejects BtuF from BtuCD [33,35]. Earlier studies were 
able to show, by utilizing the ATP hydrolysis deficient mutant, the ATP bound transition 
state [23,25,26]. This mutant has its catalytic base glutamate mutated to glutamine right 
after the Walker B motif in the NBD (E159Q-BtuCD) and can no longer hydrolyze bound 
ATP molecules, but retains the ATP binding capability. Since it was not clear whether the 
nucleotide binding and dimerization of NBDs or ATP hydrolysis caused BtuF 
dissociation, I have repeated the B12 transport experiment using the ATP hydrolysis 
deficient mutant and the result is shown below in Figure 2.18. 
 The experiment was carried out in the same way as for the wild-type BtuCD. The 
addition of E159Q-BtuCD in nanodiscs in phase III resulted in a rapid binding of B12-
loaded BtuF* to E159Q-BtuCD, which was indicated (to some extent) by the 
instantaneous increase of anisotropy and the total fluorescence The total fluorescence 
continued to increase at a slow rate, reflecting B12 moving away from BtuF*. When 0.5 
mM ATP was added, although there was a slight re-quench of fluorescence intensity, 
only very little anisotropy change was observed (the phase IV). This implied that 
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dimerization of NBDs upon binding ATP did not cause ejection of BtuF from the 
transporter: BtuF was still hanging onto BtuCD. 
 
Figure 2.18 Real-time observation of vitamin B12 transport through the ATP hydrolysis deficient mutant, 
E159Q-BtuCD, reconstituted into nanodiscs.  A: normal transport cycle with Mg-ATP.  (I) Reaction starts 
with Alexa Fluor 546 labeled BtuF.  (II) Addition and binding of B12 quenches the fluorescence.  (III) BtuCD 
reconstituted into nanodiscs is then added and de-quenches the signal as substrates move away from BtuF.  
(IV) ATP binding but most of the BtuF* remain bound and minor fraction re-binds B12 and the fluorescence 
signal gets quenched slightly. (V) Non-labeled BtuF is added and replace loosely bound BtuF*. 
 
2.3.8 Determination of the stoichiometry and affinity of BtuF* binding to BtuCD in 
nanodiscs 
 BtuF* binding to BtuCD was observed via fluorescence anisotropy to determine 
the stoichiometry and binding affinity. Fluorescence anisotropy was used to monitor the 
titration of BtuCD in nanodiscs with a fixed concentration of BtuF* (concentration of 
labeled BtuF*). Separate experiments were conducted at 40 nM, 80 nM, 120 nM, and 160 
nM nominal concentrations of BtuF*. The Kd and concentration of total BtuCD 
producing 50% binding in each experiment was calculated by fitting the data to a 
quadratic binding equation as described in the methods (Equation 2.6). The calculated 
Kds from these curve fitting ranged from 0.6~2.0 nM. To compute a more accurate 
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dissociation constant, the concentration of total BtuCD resulting in 50% binding in each 
experiment was plotted against the nominal concentration of BtuF* used in that 
experiment. These data were fitted to a linear regression to yield the dissociation constant 
(Kd) and binding stoichiometry (s) using Equation 2.7. The calculated Kd is 1.0 ±2 .3 nM 
and the stoichiometry 1.10 ± 0.05. Although the calculated affinity is lower than the one 
previously reported by Lewinson et al. [36] (~10-13M) by four orders of magnitude, the 
binding was still very tight and absolutely no dissociation of BtuF* was observed when 
an excess of non-labeled BtuF is added to each experiment. 
 
Figure 2.19 Determination of the stoichiometry and affinity of BtuF* binding to BtuCD in nanodiscs as 
described [33]. (A-E) Fluorescence anisotropy was used to monitor the titration of BtuCD in nanodiscs onto 
a fixed concentration of BtuF* at 25 ºC. Separate experiments were conducted at 40 nM, 80 nM, 120 nM, 
and 160 nM nominal concentrations of BtuF* labeled with AL546 (One with Cy3 labeled BtuF* at 80 nM). 
The concentration of total BtuCD producing 50% binding in each experiment was calculated by fitting the 
isotherm to a quadratic binding equation (Equation 2.6) as described in the Methods. (F) The concentration 
of total [BtuCD] producing 50% saturation binding in each experiment in panel (A-E) is plotted against the 
nominal concentration of [BtuF*] used in that experiment (Equation 2.8). These data were subject to linear 
regression to yield the dissociation constant (Kd) and binding stoichiometry (s): Kd is from the y-intercept 
and the stoichiometry is calculated from twice the slope. 
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2.3.9 Real-time observation of the substrate transport through the E131Q-BtuCD 
mutant 
 Finally, I have performed transport experiments with the E131Q-BtuCD (ABC 
signature LSGGEtoQ mutant) in nanodiscs in the presence or absence of divalent ion 
(Mg2+) and the results are shown in Figure 2.20. In the presence of Mg2+ ions, the results 
were almost identical to that of the wild-type BtuCD (Figure 2.20A). As I hypothesized, 
however, without added divalent ion, Mg2+, E131Q-BtuCD could not hydrolyze ATP and 
the result resembled that with the E159Q-BtuCD ATP hydrolysis mutant (Figure 2.20B). 
This confirms that BtuCD requires Mg2+ ions for efficient ATP hydrolysis to provide a 
“power-stroke” for ejecting BtuF from the transporter. 
 
Figure 2.20 Monitoring vitamin B12 transport through the BtuCD-E131Q mutant reconstituted into nanodiscs. 
(A) A normal transport cycle experiment in the presence of Mg-ATP. (B) Mg2+ ions are chelated with EDTA 
to prevent ATP hydrolysis. For both conditions, reaction starts with AF546 labeled BtuF*. Addition and 
binding of B12 quenches the fluorescence. BtuCD reconstituted into nanodiscs is then added and de-
quenches the fluorescence signal. (A) ATP binding and hydrolysis releases BtuF* which binds B12 and the 
fluorescence signal is re-quenched. This steady state continues until the competing non-labeled BtuF is 
added and depletes B12 and leaving labeled BtuF* free from B12. (B) ATP binding and dimerization is not 





2.4 Conclusions and Perspectives 
 In this chapter, I have studied vitamin B12 transport through BtuCD reconstituted 
into nanodiscs using fluorescence resonance energy transfer measurements developed by 
a former graduate student in the Hunt lab [33,35]. The results of FRET studies using 
BtuCD in nanodiscs confirm the results and conclusions drawn from a previous study 
using the transporter in bicelles [33,35]. This and previous results reveal two power 
strokes during ATP dependent B12 transport cycles. 
 
Figure 2.21 A schematic diagram summarizing the substrate transport during transport cycle. Only apo-BtuF 
can bind B12 with a high affinity. B12 is transported to the periplasmic space by coordinated actions of the 
BtuB-TonB/ExbB/ExbD complex. BtuF scavenges B12 and brings it to the inner membrane ABC transporter 
BtuCD. Type II importer BtuCD completes the transport cycle. BtuCD draws energy from ATP binding and 
hydrolysis. The first “power stroke” is coming from the dimerization of NBDs when they bind ATP molecules. 
The conformational changes in NBDs are transmitted to the TMDs through the coupling helices. ATP 
hydrolysis provides the second “power stroke” that resets the transporter back to the initial state and BtuF 
dissociates from BtuCD capturing the next available B12. 
 
 Figure 2.21 is a cartoon summarizing the vitamin B12 transport cycle of BtuCD-F. 
Once the B12-loaded BtuF binds and delivers B12 to BtuCD, the TM helices undergo 
conformational rearrangements to accommodate substrate transport through the 
permeation channel. The substrate is imported into the cytoplasmic side even in the 
absence of nucleotide, though at a slower rate as previously described [33,35,36]. The 
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power stroke from ATP binding and NBD dimerization is mediated to the TMDs via 
coupling helices, so the substrate transport process becomes accelerated. ATP hydrolysis 
resets the transporter back to the initial state and the conformational change induced by 
ATP hydrolysis causes the dissociation of BtuF, which then binds another B12. 
2.4.1 B12 uptake assay 
 In this study we interpreted B12 release as transport through the channel of 
BtuCD. Since I have not performed a separate experiment to clarity whether there is a 
release process through an unknown pathway or a proper transport through the channel, it 
was assumed that de-quenching of the fluorescence signal was equivalent to substrate 
transport. To address this question, we are in the process of developing a transport assay 
to address this ambiguity using BtuCD reconstituted into lipid vesicles.  
 Using the same FRET capability of AF546 labeled BtuF* and the substrate itself, 
labeled BtuF* incorporated the lumen of lipid vesicles works as a molecular detector. 
BtuCD is reconstituted into lipid vesicles following the protocol from Borths et al.[66]. 
Here we used E. coli total extract and extruded liposomes through a 50 nm polycarbonate 
membrane using a Mini-Extruder (Avanti Polar Lipids, Alabaster, AL). The orientation 
of the reconstituted BtuCD is randomly distributed, and we are utilizing only the ones 
reconstituted in right-side-out orientation (periplasmic side facing the outside of 
liposomes) for B12 transport analysis. Earlier in this chapter we have seen that B12 
transport can occur in the absence of added nucleotides and BtuCD reconstituted in 
inside-out orientation (NBDs facing the outside) is capable of removing imported B12 
back to the outside of the lumen as long as these transporters bind BtuF* inside. To 
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prevent this to be happening, non-interacting BtuF is used in the experiment [20,33]. As 
it was shown before [20,27], mutating two negatively charged residues (glutamtates 76 & 
202) on the surface of BtuF to positively charged residue arginines completely blocked 
binding of BtuF to BtuCD. This non-interacting BtuF mutant is still capable of binding 
B12 [33,35]. Therefore, AF546 non-interacting BtuF* would be used in the assay as a 
B12 sensor. 
 
Figure 2.22 A schematic diagram of B12 uptake assay using AF546 labeled non-interacting BtuF*. Using 
liposomes reconstituted with BtuCD, B12 transport will be detected by accumulation of labeled non-
interacting BtuF* the lumen of the liposome via fluorescence emission. Only the BtuCD inserted in the right 





2.4.2 Allosteric modulation of ATPase Activity? 
 As I briefly mentioned at the beginning of this chapter, B12 uptake in E. coli 
involves not only the BtuCD-F inner-membrane ABC transporter, but also another 
protein complex, TonB/ExbB/ExbD. This is a complex of inner-membrane proteins that 
uses proton motive force to drive B12 release from BtuB. The C-terminal domain of 
TonB extends into the outer membrane and makes contact with the TonB-box sequence 
of the N-terminal plug domain of ButB [15,21,78,79]. 
 
Figure 2.23 The periplasmic domain of ExbD resembles the N-terminal domain of BtuF. (A) BtuCD-F binding 
sites and the glutamate and arginine residues that mediate charge-charge interactions. (B) A superposition 
of the N-terminal domain of BtuF and the periplasmic C-terminal domain of ExbD [79]. Although the primary 
sequences show no significant conservation between the two proteins, the structures align quite well. 
Glutamate 72 of BtuF forms a salt bridge with the Arginines in BtuCD. At the corresponding location of ExbD 
is the aspartate 79 which might be able to form salt bridges as well.  
 
 In addition to the TonB-ButB interaction, the C-terminal domain of ExbD of 
TonB complex may deserve extra attention. The solution structure of the C-terminal 
domain of ExbD solved by NMR showed this domain resembled the N/C-terminal lobe 
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domains of the siderophore-binding proteins, BtuF, FhuD, and CeuE [15,21,79]. This 
might imply that the C-terminal domain of ExbD could interact with BtuCD in the 
absence of its cognate binding protein BtuF. Thus, it would be interesting to see whether 
ExbD can interact with BtuCD by performing a simple binding experiment. 
2.4.3 A quick preview of the next chapter 
 In this chapter we were able to monitor B12 movement through the BtuCD 
transporter in real time using FRET measurements. Although direct observation was not 
possible, each step of the transport cycle is accompanied by a corresponding 
conformation rearrangement that was required for substrate transport. Without a doubt, 
being able to monitor these individual conformational changes in real time would help us 
better understand the molecular mechanisms of the protein. So in chapter three, I will 
explain how we approached the problem of monitoring the conformational dynamics of 
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Probing the conformational dynamics of TMDs using single-molecule FRET 
 
3.1 Introduction 
 In the previous chapter I have shown that discoidal protein-lipid particles provide 
a stable native-like phospholipid environment for study of membrane proteins in isolation. 
BtuCD were successfully reconstituted into nanodiscs and exhibited ATPase activity 
similar to that of BtuCD reconstituted into liposomes. Furthermore, I have observed the 
movement of vitamin B12 through BtuCD-F using ensemble FRET measurements. The 
results of this study reaffirmed previous findings that two “power strokes” induce TMD 
conformational changes that are required for substrate transport. However, it was not yet 
possible to directly monitor detailed TMD conformational dynamics during transport 
cycle. 
 Observing the conformational dynamics of BtuCD is one of the remaining 
challenges toward providing a complete picture of the intricate association between BtuF 
and ATP binding and the corresponding conformational changes that are required for 
substrate transport. Single molecule methods can be employed to make the desired 
observations of the conformational dynamics, and improve our understanding of the 
process. Single-molecule measurements enable the observation of individual molecules 
within the population and detailed conformational information including rare and 
transient states can be revealed, which would otherwise be masked in ensemble-averaged 
measurements. The single-molecule measurements also enable one to study molecular 
kinetics without synchronizing molecules in the sample. Thus, by using this smFRET 
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measurement, I have revealed the TMD conformational changes of BtuCD during the 
transport cycle in real-time.  
3.1.1 TMD dynamics by single-molecule FRET measurements 
 Single-molecular fluorescence resonance energy transfer (FRET) is a very 
powerful technique that has enabled researchers to observe molecules with unprecedented 
resolution and precision [1-10].  
 As we saw in the previous chapter, FRET is a non-radiative energy transfer from 
a donor fluorophore to an acceptor fluorophore. FRET occurs when the emission 
spectrum of the donor fluorophore overlaps with the absorption spectrum of the acceptor 
fluorophore. Because the energy transfer occurs through a dipole-dipole interaction, the 
efficiency of energy transfer is highly sensitive to the separation distance between the 
dyes and the dyes must be physically close to each other to sense their presence through 
the means of energy transfer. The efficiency of energy transfer is inversely correlated to 
the distance to the sixth-power as shown below [11,12]:  
 ! = !!! (!!! + !!)  (3.1) 
where R is the inter-fluorophore distance, R0 is the Forster distance for any given dye pair 
at which the FRET efficiency is 50 percent. When selecting sites for dye labeling, the 
inter-dye distance should fall within R0×(1±0.5) because FRET is most sensitive to 
changes in distance within this range [13]. Several technological advances in recent years 
have made it possible for smFRET measurements to be applied to the study of protein 
folding [1,14], protein conformations and dynamics [5,9,15-17], and enzymatic reactions 
[18,19]. Although accurate distance measurements can be made, it requires correctly 
[CHAPTER)3)–)STUDY)OF)TM)DOMAIN)CONFORMATIONAL)DYNAMICS]! 77 
 
defined parameters including the orientation factor (κ2) and the spectral overlap integral 
(J(λ)), which are often hard to measure. However, the relative distance change is what we 
are interested in here instead of absolute distance measurements, and FRET is sensitive to 
short distance changes within 40~70 Å [13,20]. Thus, molecular conformational 
dynamics in this distance range will be accurately monitored using smFRET 
measurements. 
 
Figure 3.1 Florescence resonance energy transfer. (A) Absorption (blue) and emission (red) spectra of Cy3 
and Cy5 (Figure taken from Ref [13]). (B) FRET efficiency diagram drawn as a function of inter-dye distance 
for a Forster radius, R0 = 55 Å. The FRET efficiency is maximized when the two dyes come closer and it is 
minimized when the dyes are further apart. The FRET efficiency is 0.5 when R = R0. 
 
 In a typical smFRET experiment, FRET efficiency is measured from the emission 
of the donor and acceptor fluorophores and it is calculated by the following equation: 
 ! = !!""#$%&' (!!"#"$ + !!""#$%&') (3.2) 
where Idonor and Iacceptor are the fluorescence intensities of the donor and acceptor 
fluorophores, respectively. After baseline and cross-talk correction, FRET efficiencies are 
further analyzed to deduce the motions as a function of time. 
 Surface immobilization of otherwise freely diffusing molecules serves at least two 
purposes: it enables extended observation of the same molecule for much longer time 
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periods (to minutes and it is limited only by fluorophore photobleaching), and it also 
allows the illumination of only the narrow section (typically ~100-200 nm) of the surface, 
thereby greatly reducing the background fluorescence from the bulk fluids and increasing 
the signal-to-noise ratio [9,13,21]. Molecule immobilization is achieved through biotin-
streptavidin interaction as shown in Figure 3.2. In a typical setting, the microscope slide 
is passivated with polyethylene glycol (PEG) containing ~0.1% biotin-PEG to prevent 
non-specific binding of macromolecules to the slide. Onto this sparsely biotinylated PEG 
surface, the molecules of interest with biotin-linkers are attached via biotin-streptavidin 
interactions.  
 
Figure 3.2 Sample channel and surface immobilization. The sample channels are made by sandwiching a 
quartz slide and a coverslip with doubled-sided scotch tape and epoxy sealing on the edges. (A) Top-view of 
an assembled microscope slide. (B) Side-view of the slide. (C) Zoomed view of the sample channel showing 
immobilized BtuCD-nanodisc complex onto the passivated quartz slide via streptavidin-biotin linkage. 
Streptavidin with four biotin-binding sites was bound to the biotinylated PEG and the biotinylated transporter-
nanodisc complex was immobilized through biotin-streptavidin interactions. 
 
 Since the fluorescence intensity from a single molecule is very weak, smFRET is 
typically performed using total internal reflection (TIRF) microscopy. In a TIRFM setting, 
the excitation beam is totally reflected at the quartz-water interface, and this total 
reflection creates a shallow excitation field termed an evanescent field, which extends 
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~100-200 nm from the interface) that excites molecules only within this shallow region. 
Because of this limited excitation, the background fluorescence is greatly reduced and the 
signal-to-noise ratio increases substantially.  
 Example single-molecule fluorescence time trajectories and the corresponding 
FRET time trace are shown in Figure 3.3, where two fluorescence traces exhibit an anti-
correlated fluorescence change (Panel A & B). Once enough FRET traces are collected, 
data analysis can be carried out to investigate the possible protein conformational states 
(Panel D), and the lifetimes of each transition state. 
 
Figure 3.3 Single-molecule FRET data analysis. The panels A, C, D and E are example smFRET data from 
a literature by Zhao and Rueda [6]. (A) Example fluorescence time traces showing the anti-correlated donor 
and acceptor intensity change as a function of time. (C) The corresponding FRET efficiency time trace 
computed using Equation 3.2. (D) A FRET efficiency population distribution summed over time showing two 
major conformations with relative probability. (E) Dwell time distributions of the two conformations. These 
dwell time histograms are fit to single exponential decays to calculate the first order binding and dissociation 
rate constants kon and koff. 
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3.1.2 Suggested TMD conformational rearrangements during the transport cycle 
 The x-ray structures of BstuCD with and without bound BtuF suggest that the 
permeation pathway undergoes conformational rearrangements during the substrate 
translocation cycle. It has been suggested that the structure of apo BtuCD alone might 
represent the initial resting state with the permeation pathway partially open to the 
periplasmic space. The BtuCD-F complex structure is thought to correspond to an 
intermediate state prior to ATP binding and hydrolysis. The substrate translocation 
pathway switches between inward and outward facing conformations during a productive 
transport cycle. These alternating conformational changes are tightly coupled to the 
substrate translocation through the channel. However, these concerted conformational 
rearrangements have never been monitored. Thus, the goal of the project in this chapter is 
to define in detail the transmembrane domain conformational changes at various stages of 





3.2 Experimental Design and Methods 
3.2.1 Mutagenesis 
3.2.1.1 Cysless BtuCD and single cysteine BtuCD mutants 
 The primary sequences of BtuCD are shown below and nine native cysteine 
residues are highlighted in magenta (eight on BtuC and one on BtuD). First I generated a 
cysteine-less (cysless) BtuCD mutant by replacing cysteine residues on the wild-type 
BtuCD expression plasmid with serine residues. Mutations were introduced by standard 
site-directed mutagenesis using a QuikChange Multi Site-Directed Mutagenesis Kit 
(Agilent Technologies, Santa Clara, CA). Primers used in this study were designed using 
a QuikChange Primer Design program (Agilent Technologies) and are listed in Table 3.1. 
BtuC 
1 MLTLARQQQR QNIRWLLCLS VLMLLALLLS LCAGEQWISP GDWFTPRGEL 
51 FVWQIRLPRT LAVLLVGAAL AISGAVMQAL FENPLAEPGL LGVSNGAGVG 
101 LIAAVLLGQG QLPNWALGLC AIAGALIITL ILLRFARRHL STSRLLLAGV 
151 ALGIICSALM TWAIYFSTSV DLRQLMYWMM GGFGGVDWRQ SWLMLALIPV 
201 LLWICCQSRP MNMLALGEIS ARQLGLPLWF WRNVLVAATG WMVGVSVALA 
251 GAIGFIGLVI PHILRLCGLT DHRVLLPGCA LAGASALLLA DIVARLALAA 
301 AELPIGVVTA TLGAPVFIWL LLKAGR* 
BtuD 
1 MSIVMQLQDV AESTRLGPLS GEVRAGEILH LVGPNGAGKS TLLARMAGMT 
51 SGKGSIQFAG QPLEAWSATK LALHRAYLSQ QQTPPFATPV WHYLTLHQHD 
101 KTRTELLNDV AGALALDDKL GRSTNQLSGG EWQRVRLAAV VLQITPQANP 
151 AGQLLLLDEP MNSLDVAQQS ALDKILSALC QQGLAIVMSS HDLNHTLRHA 
201 HRAWLLKGGK MLASGRREEV LTPPNLAQAY GMNFRRLDIE GHRMLISTI* 
 
 Using this cysless-BtuCD as the template, a number of single cysteine mutants 
were generated. The primers used to generate single cysteine mutants are shown in Table 
3.2. All sequences were verified by a DNA sequencing service (GENEWIZ, South 
Plainfied, NJ). Mutants highlighted in red were used to study conformational dynamics in 
this Chapter. A mistake was introduced when designing a primer to make a V274C 
mutant (mistakenly used the wild-type to generate this mutant) thereby changing serine 
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279 back to cysteine (S279C). However, this cysteine was buried inside of the protein 
and was not accessible by solvent as reported previously [22-24]. So this mutant was 
used without further correcting the sequence. The mutants that were studied using 
smFRET measurements were shown in red in Table 3.2.  
Table 3.1 Primers used in cysless-BtuCD mutagenesis 
Primer ID Primer Sequence 
BtuC-C18S 5’- CAGCGACAAAATATTCGCTGGTTATTAAGCCTGTCAGTTTTG-3’ 
BtuC-C32S 5’- GGCGCTTCTCTTAAGCCTTAGCGCCGGTGA-3’ 
BtuC-C120S 5’- GGCGCTAGGGCTGAGTGCGATTGCTGG-3’ 
BtuC-C156S 5’- GGCGTTGCATTAGGGATTATCAGTAGCGCACTAATG-3’ 
BtuC-C205S 5’- CGTGTTGTTGTGGATCAGTAGTCAGTCCAGGCCGAT-3’ 
BtuC-C206S 5’- CGTGTTGTTGTGGATCAGTAGTCAGTCCAGGCCGAT-3’ 
BtuC-C267S 5’- CCCATATTCTCCGGTTGAGTGGTTTAACCGATCAT-3’ 
BtuC-C279S 5’- TTACTTCCCGGCAGCGCGCTGGCAG-3’ 
BtuD-C180S 5’- TTCTGAGCGCGCTGAGTCAGCAAGGACTG-3’ 
 
Table 3.2 Primers used in single-cysteine BtuCD mutagenesis 














3.2.1.2 Single cysteine MSP1E3D1 mutants 
 The primary sequence of MSP1E3D1 is shown below and the four C-terminal 
residues that were changed to cysteine residues are highlighted in green. As stated above, 
cysteine mutations were introduced on the wild-type MSP1E3D1 expression plasmid by 
standard site-directed mutagenesis using a QuikChange Multi Site-Directed Mutagenesis 
Kit. The primers used to generate single-cysteine MSP1E3D1 mutants are listed in Table 
3.3. All correct mutation sites were verified by a DNA sequencing service. 
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Membrane scaffold protein (MSP1E3D1) 
1 MGHHHHHHHD YDIPTTENLY FQGSTFSKLR EQLGPVTQEF WDNLEKETEG 
51 LRQEMSKDLE EVKAKVQPYL DDFQKKWQEE MELYRQKVEP LRAELQEGAR 
101 QKLHELQEKL SPLGEEMRDR ARAHVDALRT HLAPYLDDFQ KKWQEEMELY 
151 RQKVEPLRAE LQEGARQKLH ELQEKLSPLG EEMRDRARAH VDALRTHLAP 
201 YSDELRQRLA ARLEALKENG GARLAEYHAK ATEHLSTLSE KAKPALEDLR 
251 QGLLPVLESF KVSFLSALEE YTKKLNTQ 
 
Table 3.3 Primers used in cysteine MSP1E3D1 mutagenesis 
Primer ID Primer Sequence 
MSP-L275C 5’- TGTCAGCTCTGGAAGAATATACTAAAAAGTGCAATACCCAGTAAGCTTGCG-3’ 
MSP-N276C 5’- GGAAGAATATACTAAAAAGCTGTGTACCCAGTAAGCTTGCGGCC-3’ 
MSP-T277C 5’- CTCTGGAAGAATATACTAAAAAGCTGAATTGCCAGTAAGCTTGCGG-3’ 
MSP-Q278C 5’- AATATACTAAAAAGCTGAATACCTGCTAAGCTTGCGGCCGCACTCG-3’ 
 
3.2.2 Expression and purification of mutant proteins 
3.2.2.1 BtuCD mutants 
 All mutant BtuCD plasmids were transformed into E. coli C43 (DE3) expression 
host cells, and protein overexpression was done in the same way as described in Chapter 
2. Mutant BtuCD purification followed the same protocols described in Chapter 2. After 
Ni-NTA purification, the buffer was changed to a phosphate buffer at pH 7.0 using size-
exclusion chromatography for efficient labeling of thiol-groups with maleimide. The 
buffer used for size exclusion chromatography contains 50 mM NaH2PO4, pH 7.0, 200 
mM NaCl, 0.1% (w/v) LDAO, and 1 mM Tris(2-carboxyethyl)phosphine (TCEP). 
Fractions containing BtuCD were pooled and concentrated using a 100 kDa Amicon 
ultrafiltration device (EMD Millipore, Billerica, MA) pending use. 
3.2.2.2 Single-cysteine MSP1E3D1 mutants  
 All four mutant MSP1E3D1s were tested for their expression levels and all were 
expressed as well as the wild-type MSP1E3D1. Mutant purification also followed the 
protocols described in Chapter 2 with the exception of reducing agent in the buffers (5 
mM ßME in Ni-NTA buffers and 1 mM TCEP thereafter). After removing His6-tag with 
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TEV protease, the final protein was concentrated to ~130 µM in buffer containing 20 mM 
Tris-HCl, pH 7.0, 100 mM NaCl, and 1 mM TCEP.  
3.2.3 Double labeling of mutant BtuCD with Cy3 and Cy5 maleimide 
 Cy3 and Cy5 are the most commonly used dye pair for single-molecule FRET 
analysis because of their relative brightness and photo-stability [13]. Thus, all mutant 
BtuCDs were labeled with Cy3 and Cy5 for conformational dynamics studies in this 
chapter. Since the BtuCD transporter is a homodimer or two identical monomers, each 
containing one NDB and one TMD, each mutation introduced two cysteine residues, one 
on each monomer. To double label BtuCD, BtuCD in 0.1% (w/v) LDAO, 200 mM NaCl, 
1 mM TCEP, and 50 mM NaH2PO4, pH 7.0 was mixed with ~10-fold molar excess of 
Cy3 and Cy5 mixture (molar ratio of 1:1 mixture) in DMSO and incubated at 4 ºC 
overnight with gentle rotation. At the end of the overnight incubation, 20 mM ßME was 
added to the sample to quench unreacted free dyes, and double-labeled BtuCD** was 
purified by a Superdex-200-10/300 gel-filtration column (GE Healthcare, Piscataway, 
NJ) equilibrated in 0.1% (w/v) LDAO, 100 mM NaCl, 1 mM TCEP, 50 mM Tris-HCl, 
pH 7.5. The fractions containing labeled-BtuCD** were pooled and concentrated to ~8 
mg/mL using a 100 kDa Amicon ultrafiltration device. The protein concentration was 
calculated by the following equation: 
 !"#$% ! = [!!"# − (!"!×!!!")/!! + (!"!×!!"#)/!!]/! (3-1) 
where !=106,500 is the molar extinction coefficient of a homodimer of BtuCD in cm-1 M-
1 at 280 nm, !!=150,00 and !!=250,000 are Cy3 and Cy5 extinction coefficients at 552 
nm and 650 nm respectively, and CF1=0.08 and CF2=0.05 are the correction factors for 
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the absorbance of Cy3 and Cy5 at 280 nm respectively. And the degree of labeling for 
each dye was then calculated by taking the ratio of the concentration of each dye over the 
concentration of BtuCD. 
3.2.4 Biotinylation of MSP1E3D1 for surface immobilization 
 Both EZ-Link Maleimide-PEG2-Biotin and Maleimide-PEG11-Biotin (shown in 
Figure 3.4) were purchased from Thermo Scientific (Thermo Scientific, Rockford, IL). I 
initially used the PEG2-biotin with the linker length of ~30 Å, but later switched to 
PEG11-biotin to give the nanodisc complex more flexibility (~60Å). Biotin stock 
solutions were prepared by dissolving biotin reagent in DMSO. Purified MSP1E3D1 in 
100 mM NaCl, 1 mM TCEP, 20 mM Tris-HCl, pH 7.0 was mixed with ~20 fold molar 
excess of biotin reagent in DMSO and incubated at 4 ºC for overnight. At the end of the 
labeling reaction, unreacted free biotin was quenched with ~20 mM ßME and removed 
by a Superdex-200-10/300 gel-filtration column. The fractions containing MSP1E3D1-
biotin were pooled and concentrated to ~120 µM prior to flash-freezing in liquid N2 in 
300 µL aliquots and storage at -80 ºC pending use. 
 
Figure 3.4 EZ-Link Maleimide-PEG(2/11)-Biotin. Biotin linkers used in the experiment for surface 




3.2.5 Surface immobilization of BtuCD in nanodiscs for single-molecule FRET 
measurements 
 As shown in Figure 3.2C, quartz microscope slides were passivated with 
polyethylene glycol containing ~1% (w/w) biotinylated-PEG (mPEG-SPA and Biotin-
PEG-NHS-5000, Nektar, San Francisco, CA) to prevent non-specific adsorption of 
molecules onto the surface [9,21]. Biotinylated PEG was included for specific tethering 
of the molecule of interest through biotin-streptavidin interactions. The sample channels 
were assembled by sandwiching a quartz slide and a coverslip with double-sided scotch 
tape as shown in Figure 3.2A & B and the edges were sealed with epoxy to prevent 
leakage (prepared following the manual in the Gonzalez lab) [5,9,13,21]. Buffer and 
samples were delivered through the holds bored on the quartz slide in the following order. 
First, each channel was pre-washed with 200 µL of buffer containing 50 mM KCl, 10% 
Glycerol, 10 mM Tris-OAc, pH 7.5. Next, the channel was filled with 20 µL of BSA-
block solution containing 10 µM UltraPure BSA (Invitrogen, Grand Island, NY) 
containing 10 µM hybridized DNA duplex in 50 mM KCl, 10 mM Tris-OAc, pH 7.5 
(TP-50 buffer) to further prevent non-specific binding. 20 µL of 1 µM streptavidin 
(Invitrogen, Grand Island, NY) in the BSA-Block solution was delivered to the channel 
to bind streptavidin to the passivated surface via biotin-streptavidin interaction. After 
washing the channel with 1) 200 µL of TP-50 buffer and followed by 200 µL of sample 
buffer containing 150 mM NaCl, 5 mM MgCl2, 1 mM TCEP, 50 mM Tris-HCl, pH 7.5. 
Then 20 µL BtuCD in nanodiscs-biotin in the sample buffer (concentration was adjusted 
to get ~200-400 spots, typically ~20-60 pM) was bound to the surface. After washing off 
[CHAPTER)3)–)STUDY)OF)TM)DOMAIN)CONFORMATIONAL)DYNAMICS]! 87 
 
the unbound excess BtuCD in nanodiscs with 200 µL of sample buffer, the channel was 
filled with 100 µL of sample buffer containing oxygen scavenging systems and triplet 
quenchers. The final concentrations of oxygen scavenging systems and triplet quenchers 
in the buffer were 2.5 mM Protocatechuic acid (PCA, Sigma-Aldrich) and 0.25 µM 
Protocatechuate-3,4-dioxygenase (PCD, Sigma-Aldrich) and 1 mM cyclooctatetraene 
(COT) and 4-nitrobenzyl alcohol (NBA) [5,13,25,26]. 
3.2.6 Single-molecule FRET measurements 
 All smFRET measurements were performed using a wide-field prism-type total 
internal reflection fluorescence (TIRF) microscope (built as described in Blanchard et al. 
[9]) in the Gonzalez lab in the Department of Chemistry at Columbia University. Sample 
was excited with a laser beam at 532 nm (CrystaLaser, Reno, NV) and the emission 
fluorescence from both Cy3 and Cy5 fluorophores were collected simultaneously on a 
512×512 pixel eletron-multiplying charge-coupled divide (EMCCD, Cascade II, Priceton 
Instruments, Trenton, NJ) All data were collected using ~12 mW 532 nm excitation 
power and collected ~600-1000 frames per movie, at 10 frames per sec time resolution. 
~10-20 movies were recorded for each sample to obtain at least a couple hundreds of 
good traces. 
3.2.7 Data analysis 
3.2.7.1 Selecting traces and calculating FRET efficiencies using SFTracer 
 Following data acquisition, all data were initially analyzed using SFTracer written 
in Java by Victor Naumov, a graduate student in the Gonzalez lab (a screen shot of the 
program is shown in Figure 3.5). SFTracer reads in stacks of image files (normally ~600-
[CHAPTER)3)–)STUDY)OF)TM)DOMAIN)CONFORMATIONAL)DYNAMICS]! 88 
 
1000 frames per movie) and automatically aligns the donor and acceptor channels so that 
peaks in both channels co-localize. Spots were picked from the acceptor channel and 
mapped on to the donor channel, and the corresponding Cy3 and Cy5 spots were selected 
(typically finds ~200-400 spots).  
 
Figure 3.5 smFRET data analysis using SFTracer. All smFRET data were initially analyzed using SFTracer 
written in Java by Victor Naumov in the Gonzalez lab. The program reads image files, aligns the channels 
(donor and acceptor), selects spots, and calculates fluorescence intensities and FRET time traces. 
Individual traces were manually inspected and those trajectories showing anti-correlated intensity change in 
the donor and the acceptor were saved for further analysis.  
 
 Once this automatic spot selection was done, individual fluorescence traces were 
manually inspected in SFTracer (Figure 3.5, bottom right) and those traces that showed 
anti-correlated intensity change in the donor and acceptor fluorescence and single step 
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photobleaching of either or both fluorophores were saved for further analysis. The final 
fluorescence traces were corrected for baseline and bleed-through (crosstalk). 
 All FRET data from the first 5.0 sec were used to generate normalized population 
FRET distribution histograms. These histograms were plotted as either a time-averaged 
1-dimensional histogram or as a 2-dimensional time-evolution of population FRET 
histogram. 
3.2.7.2 Global analysis of FRET traces using Hidden Markov modeling 
 All FRET time traces were subjected to a non-biased global analysis and idealized 
using Hidden Markov modeling implemented in hFRET (program under development, Dr. 
Jan-Willem van de Meent in the Gonzalez lab) to determine kinetic parameters as well as 
the most probable number of conformational states for individual trajectories. Final 
idealized trajectories were further analyzed to determine the probabilities of each 




3.3 Results and Discussions 
3.3.1 Single cysteine BtuCD mutant purification 
 One of the pre-requisites for smFRET analysis is labeling the molecule of interest 
at specific locations. When fluorescently labeling proteins, fluorophores are often 
attached to thiol groups of cysteine using sulfhydryl-reactive maleimide because cysteine 
is one of the least common residues in proteins along with methionine and histidine [27].  
 The E. coli BtuCD has 9 native cysteine residues in total: 8 in BtuC and 1 in BtuD. 
It has been shown before that changing these cysteine residues to serine residues (except 
Cys279, which is buried and inaccessible to solvent) had no effect on the activity of the 
transporter based on the ATPase activity analysis [22-24,28], so here I have generated a 
cysless-BtuCD mutant and a number of single cysteine mutations on the cysless-BtuCD 
background for specific fluorescence labeling. A topology diagram of BtuC and the 
locations of the 8 native cysteine residues that were mutated to serine residues (indicated 
by solid purple dots) are shown in Figure 3.6. The Forster radius of Cy3 and Cy5 dye pair 
is ~55 Å, and this gives a sensitive detectable distance range of 30~80 Å (0.5R0 < R < 
1.5R0) [13,29]. Thus, when selecting sites for cysteine mutations, two things were 
considered: low sequence conservation at the position, and inter-domain distance within 
the optimal range. Based on these criteria, a number of single cysteine mutations were 
generated at the locations marked with green dots (Figure 3.6, all mutant are listed in 
Table 3.2), and the results from the three mutants are indicated with arrows (Gln111, 





Figure 3.6 Topology diagram of BtuC. BtuC has 10 transmembrane helices and cysteine residues that were 
mutated to serine residue are shown in pink circles. To introduce fluorescent dyes (Cy3 and Cy5 maleimide), 
single cysteine mutants were generated by standard site-directed mutagenesis using the cysless-BtuCD as 
a template and the positions are shown here with green circles. The mutants that were subjected to 
smFRET analysis are indicated with an arrow and the residue name. 
 
3.3.2 Purification of double-labeled BtuCD 
 All mutant BtuCDs carrying a cysteine residue on each of the two BtuC were 
double-labeled with Cy3 and Cy5 as described in the method. Briefly, labeling was done 
by adding equimolar amounts of Cy3 and Cy5 dyes to the protein solution and incubating 
at 4 ºC overnight with gentle rotation. Double-labeled BtuCDs were purified by a gel-
filtration, and the degree of labeling was determined from the concentrations of the 
protein, Cy3 and Cy5, all measured spectrophotometrically. For example, the labeling 
efficiencies of V274C-BtuCD were 37% and 33% for Cy3 and Cy5 dyes, respectively, 
and in Q111C-BtuCD, they were 46% and 50% for Cy3 and Cy5, respectively. Unlike a 
single fluorophore labeling where the possible outcome is either labeled or unlabeled, 
double labeling would produce six different molecular variants because labeling is often 




Figure 3.7 Six possible outcomes of double labeling. Only the FRET signals from the Cy3-Cy5 (boxed) will 
be used in the analysis. It would be optimal if double-labeled proteins could be cleanly separated from the 
other species, but the proteins were used without any further purification. 
 
 Proteins with correct double labels (boxed one in Figure 3.7) can be separated 
from the other species by a hydrophobic interaction chromatography (HIC) [5]. However, 
the use of HIC for purifying membrane proteins is not suitable because detergents bind 
the matrix very strongly [30]. So here I used double-labeled BtuCD without any further 
purification. 
3.3.3 Double-labeled BtuCD reconstitution into nanodiscs using biotinylated-
MSP1E3D1 
 Double-labeled BtuCD** was reconstituted into nanodiscs using biotinylated-
MSP1E3D1 as described in the method in Chapter 2. MSP1E3D1 was biotinlyated for the 
complex to be immobilized on a quartz slide. A biotin linker of ~60 Å was attached to a 
cysteine residue on the C-terminal end of MSP1E3D1. Although not routinely, the biotin 
labeling efficiency was calculated using the HABA (4’-hydroxyazobenzene-2-carboxylic 
acid) method (The Pierce Biotin Quantitation Kit, Thermo Scientific, Rockford, IL), and 
MSP1E3D1 was over 65% biotinylated. 
 Following reconstitution, BtuCD-nanodisc complex was purified using a 
Superdex-200-10/300 gel-filtration column. The fractions containing BtuCD-nanodiscs 
were pooled and loaded onto a Ni-NTA column (~500µL resin) equilibrated in 100 mM 
[CHAPTER)3)–)STUDY)OF)TM)DOMAIN)CONFORMATIONAL)DYNAMICS]! 93 
 
NaCl, 1 mM TCEP, 20 mM Tris-HCl, pH 7.5 to remove excess amount of empty 
nanodiscs. Since BtuCD still has an N-terminal His10-tag, only the nanodisc complexes 
reconstituted BtuCD would bind to the Ni-NTA resin and would be eluted with the buffer 
containing 300 mM imidazole. After Ni-NTA affinity purification, the imidazole was 
removed using a PD-10 desalting column (GE Healthcare, Piscataway, NJ), and the final 
BtuCD-nandisc complex was concentrated to 1~2 µM using a 100 kDa Amicon 
ultrafiltration device. The final concentrate was filtered using a Spin-X centrifuge tube 
filter (Corning, Tewksbury, MA). 
3.3.4 TMD conformational studies using smFRET measurements 
3.3.4.1 Specific surface immobilization via biotin-streptavidin interaction 
 In order to test whether the surface binding was specifically through biotin-
streptavidin interactions, two fluorescent labeled empty nanodiscs were prepared using 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) containing ~1% fluorescently 
labeled lipids (16:0 Liss Rhod PE, Avanti Polar lipids, Alabaster, AL): one with non-
biotinlyated MSP1E3D1 and the other with biotinylated MSP1E3D1. Images were taken 
by directly exciting the donor channel (the absorption spectrum of rhodamine B is similar 
to Cy3 or Alexa Fluor 546). Similarly, double-labeled BtuCD-nanodisc complexes were 
also prepared with and without biotin linkers and tested for their surface binding. The 
results are shown in Figure 3.8 where the two images (A) and (B) are for non-biotinylated 
and biotinylated BtuCD-nanodisc complexes, respectively. The images were analyzed 
using a MetaMorph (Molecular Devices, Sunnyvale, CA), and the numbers of spots on 
each image were counted for comparison using three different threshold cutoffs. The 
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numbers were plotted as shown in Figure 3.8C, D. For both fluorescent-labeled empty 
nanodiscs and the BtuCD-nanodisc complexes, the non-specific binding was less than 
10% of the specifically attached samples.  
 
Figure 3.8 Surface immobilization assay. Both fluorescent labeled empty nanodiscs and BtuCD-nanodisc 
complex were tested for specific surface immobilization. (A) An image taken with BtuCD-nanodisc complex 
without biotin linker. A small number of spots were observed as a result of non-specific binding of molecules 
to the surface. (B) An image of the BtuCD-nanodisc complex with biotin linker. Compared to the non-
biotinylated complex, a lot more spots were observed. 40~80 pM samples were delivered to both channels. 
(C, D) Histograms showing the average number of spots identified for both non-biotinylated and biotinylated 
complexes above threshold cutoffs. Three intensity threshold cutoffs were chosen to pick spots and 
numbers were counted for each threshold. In all cases, the non-specific binding was < 10% of the specific 
binding. 
 
3.3.4.2 Conformational dynamics of the cytoplasmic end of TM9 
3.3.4.2.a FRET efficiency distribution of BtuCD transporter 
Table 3.4 Inter-residue (V274) distances and the calculated FRET efficiencies 
 BtuCD (1L7V) BtuCD-F (2QI9) 
Cα-Cα distances (Å) 54.1 54.9 
Calculated FRET (R0=55Å) 0.52 0.50 
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 After verifying that the binding was specific, I monitored the TMD 
conformational dynamics at the cytoplasmic end of TM9 during transport cycle. 
Fluorescent probes (Cy3 and Cy5) were introduced at position V274 of BtuC and the 
inter-residue distance changes were observed using smFRET measurements in real-time. 
Cy3 and Cy5 double-labeled BtuCD in nanodiscs were tethered onto the microscope slide, 
and smFRET movies were recorded. The FRET efficiencies of selected traces were 
computed by taking the ratios of acceptor intensity over the total intensity (corrected for 
baseline and bleed-through). Representative individual fluorescence time traces and their 
corresponding FRET traces are shown in Figure 3.9A. Visual inspection of these traces 
(and the majority of the traces) shows that the residue at this position exhibited limited 
dynamics with small fluctuations. A population FRET distribution histogram was 
generated for all FRET traces from the first 5 seconds and plotted as a two-dimensional 
time-evolution FRET histogram as shown in Figure 3.10A (a time-averaged population 
FRET distribution was generated and put next to the 2-dimensional histogram). These 
two plots identified a major conformational state with the FRET efficiency (E) centered 
at 0.42. As implied from the individual representative traces, the width of the histograms 
is narrow, indicating the conformational dynamics of TM9 at the cytoplasmic end are 
confined to a limited region when the transporter is in the resting state.  
 Although the population of FRET distributions clearly show the major 
conformational state, conformational states that are similar to one another cannot be 
identified easily. Thus, all FRET values were subjected to a more rigorous analysis using 
Hidden Markov modeling (hFRET) to determine the number of most probable 
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conformational states and their relative populations. hFRET found five distinct 
conformational states with the major conformation at E=0.42 ± 0.03, which would 
roughly correspond to a distance of ~58 ± 1Å using the Forster radius of 55Å 
(approximate R0 for Cy3-Cy5 pair). Since accurate distance measurements require a 
careful calibration of several parameters and it was not the objective of this study, instead 
I focused on the relative conformational changes. It was nonetheless exciting to see the 
derived distance from smFRET measurements agreed quite well the distance from the x-
ray structure (54.1 Å Cα-Cα distance at V274 from BtuCD, PDB: 1L7V, Table 3.4). 
 
Figure 3.9 Example single-molecule traces of BtuCD at position V274C. Example individual fluorescence 
traces of BtuCD-V274C without (A) and with BtuF. Fluorescence time traces (Cy3 donor in green and Cy5 
acceptor in red) are shown on top of each panel showing characteristic anti-correlations and single step 
photo-bleaching. Their corresponding FRET time traces are shown below the fluorescence traces. BtuCD-F 




 A transition density plot (TDP) was generated by plotting average FRET values 
before (initial FRET) and after (final FRET) each transition as a two-dimensional heat 
map as shown in Figure 3.10B. Although the transition rates among different states are 
yet to be determined, the TDP plot shows the three most probable conformational states 
(E= ~0.2, E= ~0.4, and E= ~0.6) and identifies that the most prominent transition occurs 
from E= ~0.6 to E= ~0.4. 
 
Figure 3.10 Dynamics of the cytoplasmic end of TM9 (V274) before and after BtuF binding. (A, C) The 
histograms of FRET traces from the first 5 sec for BtuCD alone (Panel A) and BtuCD-F (Panel C), plotted as 
both two-dimensional time-evolution FRET distribution histogram and a time-averaged one-dimensional 
histogram. (B, D) Transition density plot for BtuCD (Panel B) and BtuCD-F (Panel D) are generated by 
plotting the “Initial FRET” versus “Final FRET” for each transition as contour plots of two-dimensional 
population histograms. 
 




 The inter-residue (domain) distance at V274 from the structure of BtuCD 
complexed with BtuF (BtuCD-F) is almost identical to that calculated from the structure 
of BtuCD as shown in Table 3.4 [24,31]. This implies that BtuF biding alone would not 
induce any conformational changes at this location. In order to see whether BtuF binding 
induces any conformational changes at this location of BtuCD, BtuCD-F complex was 
subjected to smFRET measurements. Double-labeled BtuCD in biotinylated-nanodiscs 
was pre-incubated with ~5-fold molar excess of non-labeled BtuF (~1 µM BtuCD was 
mixed with ~5 µM ButF). The BtuCD-F-nanodisc complex was diluted shortly before 
delivering into the sample chamber in order to minimize unwanted dissociation of the 
complex. Example fluorescence time traces and the corresponding FRET time traces are 
shown in Figure 3.9B. Quick inspection of these traces indicates very different dynamics 
of TM9 at position V274; BtuF binding resulted in the cytoplasmic end of TM9 to exhibit 
increased dynamics indicated by frequent fluctuations and also much larger distance 
fluctuations compared with those of BtuCD alone. 
 Both the two-dimensional FRET histogram and the time averaged population 
FRET distribution histograms show that TM9 at V274 sampled conformational states that 
were separated by very long distances. The occupancies of higher FRET states increased 
substantially, reflecting the TM9 V274s were brought closer together as a result of BtuF 
binding. 
 As before, several major conformational states were determined by hFRET as 
they are shown next to the 1D-histogram in Figure 3.10C. This demonstrates that the 
probabilities of the higher FRET states have increased substantially, confirming that these 
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two positions were brought closer. Both inter-residue distances and the conformational 
dynamics of this location seem very different to the distance observed in the crystal 
structure of BtuCD-F complex, which showed no change from the structure of BtuCD 
alone. In Chapter 2, I have shown that B12 can be transported even in the absence of 
nucleotide, implying that the TMDs undergo substantial conformational changes when 
BtuF binds to BtuCD. 
 The transition density plot shows six most prevalent transitions between initial 
and final FRET states (E= ~0.39, E= ~0.57, and E= ~0.77). They are shifted upward 
compared to those of BtuCD alone (3.10D). The density indicates the higher FRET states 
are more frequently occupied and that the transition from E= ~0.57 to E= ~0.77 has the 
highest probability. 
3.3.4.2.c Conformational changes induced by ATP binding 
 In order to see the conformational states that were induced by ATP binding and 
NBD dimerization, the same E159Q mutation was introduced to the V274C-BtuCD 
mutant. The sample size was much smaller than others, so care must be taken when 
interpreting the data. All the 201 traces were analyzed and the results are shown in Figure 
3.11B. The population FRET distribution histograms show a broad distribution of 
distances indicating that the TM9 at V274 still exhibited increased dynamics as opposed 
to being constrained to one conformation. But more importantly, as the histograms show, 
the major conformational state was found at E= ~0.26, which might indicate that ATP 
binding and NBDs dimerization induces opening of the cytoplasmic end of TM9. Earlier 
studies on the conformational dynamics of BtuCD using electron paramagnetic resonance 
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(EPR) spectroscopy suggested that ATP binding and dimerization induced opening of the 
cytoplasmic end of TM5 (thought to be one of the channel forming helices) [22,23]. 
Although the probed sites were different, the conformational state of TM9 at V274 using 
ATP hydrolysis deficient mutant agrees well with the previous findings. 
 
Figure 3.11 Effect of ATP binding on TM9 at V274. As in Figure 3.10, the histograms of FRET traces from 
the first 5 sec for BtuCD-F complex (Panel A) and ATP bound E159Q-BtuCD-F complex (ATP hydrolysis 
deficient mutant) (Panel B), plotted as both two-dimensional time-evolution FRET distribution histogram and 
a time-averaged one-dimensional histogram. The major conformational state of ATP hydrolysis mutant 
E159Q-BtuCD-F is lower than that of BtuCD-F or BtuCD indicating ATP binding pushed the TM9 at V274 
further apart. 
 
3.3.4.3 Conformational dynamics of the periplasmic end of the TM9 
Table 3.5 Inter-residue (A299) distances and the calculated FRET efficiencies 
 BtuCD (1L7V) BtuCD-F (2QI9) 
Cα-Cα distances (Å) 37.3 44.3 
Calculated FRET (R0=55Å) 0.91 0.79 
 
 Next, I monitored the conformational dynamics of the same TM9 but on the 
periplasmic end of it. The Cy3 and Cy5 fluorophores were introduced at position A299 
(A299C-BtuCD) on the periplasmic end of TM9 and as before smFRET data were 
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collected in the same way as V274C-BtuCD. The inter-residue distances from two x-ray 
structures and their corresponding FRET efficiency values are shown in Table 3.5.  
 
Figure 3.12 Dynamics of the periplasmic end of TM9 (A299) before and after BtuF binding. (A, C) The 
histograms of FRET traces from the first 5 sec for BtuCD alone (Panel A) and BtuCD-F (Panel C), plotted as 
both two-dimensional time-evolution FRET distribution histogram and a time-averaged one-dimensional 
histogram. (B, D) Transition density plots for BtuCD (Panel B) and BtuCD-F (Panel D) are generated by 
plotting the “Initial FRET” versus “Final FRET” for each transition as contour plots of two-dimensional 
population histograms. 
 
 Figure 3.12A shows the population FRET distribution histograms with the most 
probable states determined from hFRET. The major FRET peak was found at E= 0.87 ± 
0.01 and it agrees well with the FRET value calculated from the crystal structure. The 
width of the FRET distribution indicates the residues at this location undergo small 
fluctuations, which agrees well with the result from V274C-BtuCD. So combined 
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together, both ends of TM9 exhibited limited conformational dynamics when the 
transporter was in the resting state with no extra stimuli. 
 The transition density plot shows the major transition between E= ~0.71 and E= 
~0.87 and that the frequent transition occurs from the lower to the higher FRET state. 
 The results from A299C-BtuCD-F show that the periplasmic end of TM9 was 
pushed outward as a result of BtuF binding to BtuCD as indicated by slightly lowered 
FRET states in Figure 3.12C. The width of the population FRET distribution histogram 
was also wider than that of BtuCD, indicating increased dynamics at this position, which 
again agrees well with the result from the other end of TM9. 
 Taken together, the results from two smFRET measurements suggest that BtuF 
binding causes a tilting motion of the TM9: the periplasmic side was pushed outward 
while the cytoplasmic side was pushed inward and vice versa. 
3.3.4.4 Conformational dynamics of the ECL2 (connects TM3-TM4) 
Table 3.6 Inter-residue (Q111) distances and the calculated FRET efficiencies 
 BtuCD (1L7V) BtuCD-F (2QI9) 
Cα-Cα distances (Å) 54.1 46.8 
Calculated FRET (R0=55Å) 0.52 0.72 
 
 Lastly, I have introduced fluorescent probes into ECL-2 at Q111 to monitor 
conformational dynamics of the loop connecting TM3-TM4. The inter-residue distances 
at this position from the two structures differ by 7.3Å (or ∆E= 0.2, see Table 3.6), 
suggesting that this might be a good structure to study. 
 The FRET probability distribution of BtuCD alone at position Q111C showed 
wide distance distribution with at least two major conformational states centered at E= 
0.69 (53%) and E= 0.48 (22%); these FRET values correspond to a separation distance of 
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7.6Å, which matches almost exactly to the distance difference of two conformational 
states observed in the crystal structures [24,31].  The broad FRET distribution indicates 
that the ECL-2 region of BtuCD in its resting state is quite mobile and samples multiple 
conformational states including those two observed in the crystal structures (Figure 
3.13A). The most probable conformational state at ECL-2 (E= ~0.69) determined from 
smFRET measurements, however, differs from that of the crystal structure of BtuCD; 
instead, it resembles the conformational state observed in the BtuCD-F complex structure. 
 
Figure 3.13 Dynamics of the ECL-2 (Q111) before and after BtuF binding. (A, C) The histograms of FRET 
traces from the first 5 sec for BtuCD alone (Panel A) and BtuCD-F (Panel C), plotted as both two-
dimensional time-evolution FRET distribution histogram and a time-averaged one-dimensional histogram. (B, 
D) Transition density plot for BtuCD (Panel B) and BtuCD-F (Panel D) are generated by plotting the “Initial 




 A closer look at the crystal structure of BtuCD might provide clues to this 
discrepancy. Figure 3.14 shows the structure of BtuCD (PDB: 1L7V) with the residue 
average B-factors depicted as worms with variable thickness and color (blue: low B-
factor and red: high B-factor). Noticeably, the average temperature factors on the 
extracellular regions including the position Q111 are among the highest of the transporter, 
which indicates that these extracellular regions are highly flexible when the transporter is 
in the resting state. This agrees well with the results from smFRET measurement. 
Moreover, the periplasmic regions of BtuCD form four crystal lattice contacts with 
neighboring BtuCDs: two through the ECL-1 and two through the ECL-2 as shown in 
Figure 3.14C (only one ECL-2 contact is depicted for the sake of simplicity). Thus it is 
possible that crystal lattice contacts between ECL-2 (Q111) and the NBD domain of a 
neighboring molecule might have favored the wide-open conformation at this position 
(this crystal lattice contact is not observed in the BtuCD-F complex structure). Since 
ELC-2 connects TM3-TM4, it would be interesting to know the conformational states at 
the other end of these TM helices. 
 Like other mutants, the ECL-2 double-labeled BtuCD-F complex was prepared 
and smFRET measurements were taken to see whether BtuF binding induced 
conformational changes at the position. The population FRET distribution histogram of 
the ECL-2 double-labeled BtuCD-F complex immediately shows the difference 
compared with that of BtuCD. The width of the distance distribution was much narrower 
and the major conformational state shifted upward to center at E= 0.72, which resembles 




Figure 3.14 BtuCD structure rendered by the average B-factor (PDB: 1L7V). (A-B) Looking from different 
angles; a side-view and a top view. (C) Shows the crystal lattice contact sites. The periplasmic side of 
BtuCD makes four contacts with neighboring molecules: two at the region near the ECL-1 which makes 
contact with the ECL-1 of the neighboring BtuCD, and two contacts through ECL-2 (which contains Q111) 






3.4 Conclusions and Perspectives 
 In this chapter, I have shown that smFRET can be successfully applied to study 
the conformational dynamics of membrane transporters during the transport cycle. Using 
site-specifically double-labeled BtuCD, it was possible to directly monitor 
conformational dynamics of TMDs induced by binding of its cognate substrate-binding 
protein, BtuF. The crystal structures of BtuCD available and other biophysical studies 
suggested that BtuCD might employ different channel gating mechanisms than ABC 
exporters or type I importers, but the very nature of the conformational rearrangements 
during transport cycle had remained unresolved. 
 Using smFRET measurements, I have showed that it is possible to observe the 
conformational dynamics of BtuCD at various stages during the transport cycle in real 
time. The results provided detailed insights into the tightly coupled conformational 
coupling between different domains of the transporter. 
 In the resting state, the TMD conformational states at the positions studied 
resemble the states observed in the crystal structure of BtuCD with the exception of the 
ECL-2 region, which was closer to the state found in the BtuCD-F complex structure. 
BtuF binding and forming the BtuCD-F complex induces conformational changes at all 
three locations studied (Figure 3.15B). And lastly, ATP binding and NBD dimerization 
causes opening of the cytoplasmic end of TM9, implying that the permeation channel 
opens to the cytoplasmic side to accommodate the final release of the substrate to the 




Figure 3.15 A summary of conformational changes of TM helices during the substrate transport cycle. TMDs 
are shown with looking down from the periplasmic space. The probe locations are depicted as green and red 
dots for covalently attached Cy3 and Cy5, respectively. The relative distance changes of the positions 
responding to the stimuli (BtuF binding and ATP binding) are shown with arrows indicating the possible 
directions of movement. 
 
 This project has only scratched the surface of fully understanding all the structural 
changes involved in the transport process, and much remains to be accomplished in the 
future. As stated earlier, more experiments with ATP hydrolysis deficient mutant, 
E159Q-V274C-BtuCD should be done to clarify whether the wide distance distribution 
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Summary of crystallization of ABC transporters: 




 A high-resolution protein structure could yield invaluable insights into the 
molecular mechanisms of a protein of interest, as it provides the overall shape of the 
protein, possibly reveals the binding/catalytic site(s), and the functionally important 
residues. The available x-ray structures thus provide invaluable insights into the 
functional and conformation dynamic studies of BtuCD. However, proteins in solution 
are dynamic macromolecules which are constantly moving. Crystallographic snapshots 
therefore do not provide a complete insight into the function of the protein. One of the 
missing states required for a better understanding the substrate transport cycle of BtuCD 
is the closed NBD dimer state in which two ATP molecules are tightly bound at the dimer 
interface. This state has thus far been elusive and the structure of the ATP-bound state 
has yet to be reported. 
 Before re-directing the focus of my graduate studies to mechanistic studies of E. 
coli BtuCD about 2 years ago, I had worked on crystallization of ABC transporters and 
ABC exporters including the E. coli lipid flippase MsbA and its homologs from different 
bacterial species. Although I have made a number of improvements with respect to MsbA 
crystallization, the project did not yield x-ray diffraction-quality crystals. This chapter 
will thus be a summary of the ABC transporter crystallization attempts, starting with the 
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result of a recent brief trial of BtuCD crystallization followed by short summaries on 
other ABC transporters that I have worked on during my graduate years. 
4.1.1 Crystallization of BtuCD 
 E. coli BtuCD was the first full-length ABC transporter for which the crystals 
structure was solved by x-ray crystallography in 2002 [1]. Although the structure of E. 
coli MsbA was determined a year earlier, the authors later retracted the structure along 
with their other high profile structures due to the errors introduced while refining the 
structures [2]. The apo-BtuCD structure was solved to 3.2 Å resolution and revealed 
complete TMDs and NBDs. Although the structures of several soluble NBDs have since 
been reported and some of them in dimer conformations suggesting possible dimerization 
of NBDs [3,4], it still was still very controversial which one of them represents the 
correct closed dimer conformation. The structure of the NBDs of this apo-BtuCD [1] and 
shortly after the structure of the closed dimer of MJ0796 [5] both clearly showed the 
head-to-tail NBD dimer conformation. The ABC dimer of MJ0796 revealed two ATP 
molecules sandwiched at the dimer interface secured by the Walker A motif of one NBD, 
and the signature motif from the other NBD [5]. 
 Unlike the ABC dimer of MJ0796, no nucleotides were found in the NBDs of 
BtuCD; instead two tetra-vanadates were bound at the dimer interface, so it was proposed 
that the structure represented the initial resting state with its permeation channel open to 
the periplasmic space [1,6-10]. However, as was shown in Figure 2.4A in Chapter 2, the 
channel opening of a close homolog of BtuCD suggests otherwise. The HI1470/71, a 
putative metal-chelate type ABC importer (a class type II importer) from Haemophilus 
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influenza was solved to 2.4 Å resolution [11]. Like apo-BtuCD, HI1470/71 was solved in 
a nucleotide free state, but its permeation channel is open to the cytoplasm. 
 The second structure of BtuCD, a complex with BtuF, came out about five years 
after the first apo-BtuCD. The BtuCD-F complexed structure was determined to a 
resolution 2.6 Å and revealed substantial TMD conformational changes compare to the 
apo-BtuCD; the channel was occluded in the BtuCD-F complex structure [7]. The 
structure was solved in the absence of nucleotide and the conformations of the NBDs 
were very similar to those of the apo-BtuCD structure. Recently the same group 
determined another BtuCD-F complexed structure [12]. The latest BtuCD-F complexed 
structure is an ATP-hydrolyzed deficient mutant (E159Q) so as to trap ATP in the dimer 
interface, though no nucleotide was found at the dimer interface and the structure was 
similar to the previous BtuCD-F complex structure [12]. 
 ATPase activity analysis in Chapter 2 showed the E131Q-BtuCD mutant (a 
canonicalization of the ABC signature motif from LSGGE to LSGGQ) was 
thermodynamically more tightly coupled. The E131Q-BtuCD in nanodiscs had a lower 
basal ATPase activity and the substrate-induced hydrolysis stimulation was larger. I have 
thus generated an ATP-hydrolysis-deficient E159Q mutant on the E131Q-BtuCD 
background to see if this mutant could stably capture nucleotides at the dimer interface. 
4.1.2 E. coli lipid flippase MsbA 
 The outer membrane of gram-negative bacteria is highly asymmetric in that the 
inner leaflet is composed of phospholipids and the outer leaflet contains 
lipopolysaccharide (LPS) [13-15]. LPS is an endotoxin and elicits a strong immune 
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response in mammalian cells [15]. The lipid-A moiety of the LPS core is synthesized in 
the cytoplasm and transported to the outer membrane by cooperative actions of multiple 
proteins as shown schematically in Figure 4.1 [16,17]. At the beginning of this transport 
process is the E. coli MsbA, which functions as a lipid flippase as it flips nascent lipid-A 
to the outer leaflet of the inner membrane. MsbA has received much attention for not 
only is it the only known ABC transporter that is essential for cell survival, but also 
because it is a close homolog of the human multi-drug resistance (MDR) ABC 
transporters MDR1 and MDR3 [18-20], which are capable of recognizing MDR 
substrates.  
 MsbA is a homodimer, comprised of two halves transporters, each of which 
consists of a TMD fused to an NBD (Figure 1.1D in Chapter 1). Each TMD consists of 6 
transmembrane helices forming a tight helical bundle, and unlike that of ABC importers, 
it extends further down to the cytoplasm forming an intra-cellular domain (ICD) between 
TMD and NBD. 
 Four structures of MsbA have been determined so far: two apo structures (an 
open-apo and a closed-apo) and two holo-MsbA structures with bound nucleotides (one 
with ADP+Vi and the other with AMP-PNP) [18]. The substrate permeation channels of 
both holo structures are open to the periplasmic space as also seen in the Sav1866 
structures from Staphylococcus aureus [18,21,22], indicating that nucleotide binding 
induces conformational rearrangement in the TMD domain. The conformational states of 
the apo-MsbA structures, however, are more interesting. The channels of both structures 
are open to the cytoplasm in varying degrees. The channel of the open-apo is wide open 
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to the cytoplasm and its NBDs do not make any contact but are separated by 
approximately 50 Å [18]. In contrast, the overall conformation of the closed-apo structure 
is more compact, resembling those of holo-MsbA structures. The channel opening of 
holo-MsbA structures is much more narrow and its NBDs make substantial contacts to 
each other [18]. Although these structures provided insights into the molecular 
mechanisms of the transporter, the overall qualities of the structures (resolutions range 
from 3.7~6.2 Å, the AMP-PNP bound structures was solved to 3.7 Å and the others at 
4.2~6.2 Å) make it hard to draw concrete conclusions from the structures. Whether the 
wide-open conformation of the apo-MsbA represents a true physiological conformation 
has remained particularly controversial. For this reason, it would have been insightful to 
determine a structure at a higher resolution than those of currently available structures. 
Therefore, multi-faceted approaches have been tried that produced positive results that 
can be further tested and optimized in future experiments. 
 
Figure 4.1 A cartoon diagram of lipopolysaccharide (LPS) transport in E. coli [23]. LSP is synthesized in the 
cytoplasm and transported to the outer leaflet of the outer membrane. At the beginning of the process, MsbA 
flips LSP from the cytoplasm to the outer leaflet of the inner membrane. Another ABC transporter LptFGB is 
involved in the transport of LPS to the outer membrane with the help from LptA periplasmic binding protein. 
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4.1.3 Lanthionine containing antibiotic peptides transporters 
 Lanthionine containing antibiotics (lantibiotics) are short ribosomally synthesized 
polycyclic antibacterial peptides [24-27]. These peptides are synthesized by gram-
positive bacteria as pre-peptides that undergo extensive post-translational modifications 
by a series of enzymes, dehydratase, cyclase, and protease, before being transported out 
of the cell [28-32]. Once exported, lantibiotics attack other gram-positive bacteria by 
specifically binding to the phosphate moiety of lipid II molecules [26,33-36]. This very 
action of lipid II binding of lantibiotics results in killing of the target bacteria by either 
forming pores in the membrane as shown in Figure 4.2C (cells lose their contents through 
the pores) or interfering with the cell wall biogenesis (Figure 4.2A, lipid II can no longer 
deliver peptidoglycan subunits) [24,26,33,34,37]. The last step of lantibiotic synthesis is 
the secretion of the nascent peptides for the process of which an ABC transporter is 
responsible [29,32]. 
 Lantiboitic transporters HalT and LanT from Bacillus halodurans and Bacillus 
licheniformis, respectively, are bi-functional proteins comprising a canonical ABC 
transporter and an N-terminal cysteine protease domain [25,35,37]. The protease domain 
binds and cleaves off the leader peptide and the ABC transporter exports the peptides 
using the energy of ATP binding and hydrolysis. These bi-functional transporters are 
attractive proteins to study for a number of reasons: 1) no bi-functional ABC transporter 
structure has thus far been solved in which the structure could reveal how the N-terminal 
protease is arranged and interacts with the rest of the transporter, 2) since the proteins 
have known substrates, the design of follow-up studies and the mechanistic studies will 
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be easier to conduct, and 3) since the substrates are clinically relevant and can be possibly 
used as an alternative to currently available antibiotics, structural information will greatly 
speed up our understanding of the molecular mechanisms of these transporters.  
 For every antibiotic in clinical use, an antibiotic-resistance strain has emerged 
much more quickly than anyone might have imagined. So far, no antibiotic has escaped 
resistance, and we are greatly in need of a new class of antibiotics to combat the resistant 
pathogens. The studies on lantibiotics might open up a new way to approach the problem. 
 
Figure 4.2 The cell wall biogenesis in gram-positive bacteria and the point of interference of clinically 
available antibiotics. (A) Clinically available antibiotics and their modes of action. (B) A broad spectrum 
antibacterial peptide, Nisin, used in food industry as a preservative. (C) A schematic diagram showing Nisin 
binding lipid II through its phosphate moiety and forming a pore. The pore makes the cell membrane of the 









4.2  Experimental Design and Methods 
4.2.1 Double E131Q/E159Q-BtuCD mutant expression and purification 
 A E131Q/E159Q-BtuCD mutant was generated by site-directed mutagenesis 
using E159Q-BtuCD as a template. The correct introduction of the mutation was verified 
by DNA sequencing (GENEWIZ, South Plainfield, NJ). The plasmid was transformed 
into E. coli C43 (DE3) cells for protein expression, and the mutant protein was purified 
according to the protocol described in Chapter 2. Briefly, fractionated membranes were 
solubilized with 1.5% LDAO (Anatrace, Maumie, OH) and the solubilized mutant protein 
was purified by Ni-NTA chromatography and a Superdex-200-10/300 gel-filtration 
column (GE healthcare, Piscataway, NJ) in the presence of 0.1% LDAO. Purified 
E131Q/E159Q-BtuCD was concentrated to ~14mg/mL using a 100 kDa Amicon 
ultrafiltration device (EMD Millipore, Billerica, MA). All steps were carried out at 4ºC. 
4.2.2 E. coli MsbA expression and purification 
 Before I took over the MsbA crystallization project, a former postdoc and 
technician worked on the project and established the protocols for protein expression and 
purification. Protein was expressed in E. coli C43 (DE3) cells grown in TB supplemented 
with 100 µg/mL kanamycin and 1.0% glycerol. The culture was grown at 25 ºC and when 
the cell density reached OD600 of ~0.75 MsbA expression was induced with 2 mM IPTG 
(Gold Biotechnology, St. Louis, MO). Protein expression was continued for an additional 
16 hours at 25 °C with shaking at 275 rpm. 
 All purification steps were performed at 4 °C. Cells were harvested by 
centrifugation and washed a few times in a buffer consisting of 50 mM Tris-HCl, pH 7.5, 
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100 mM NaCl. Cells were resuspended in 5 mL of buffer A (50 mM Tris-HCl, pH 7.5, 
100 mM NaCl, 2 mM EDTA, 2 mM DTT, protease inhibitor cocktail (Complete EDTA-
free tablets, Roche, Indianapolis, IN), 4 mg/mL lysozyme (Sigma-Aldrich, St. Louis, 
MO)) per gram wet cells, and incubated at 4 ºC for 1 hour with gentle stirring. Cells were 
lysed, and membranes were collected by centrifugation at ~30,000 g for 1 hour. The 
pellet was resuspended in a buffer B (50 mM KH2PO4, pH 7.25, 300 mM NaCl, 10% 
Glycerol, 30 mM imidazole, 1 mM EDTA, protease inhibitor cocktail) containing 1.0% 
ß-DDM (Anatrace, Maumee, OH) and 0.01% E. coli polar lipids (Avanti Polar Lipids, 
Alabaster, AL)), and protein extraction was carried out with gentle stirring for 2 hours at 
4 ºC. The solubilized lysates were cleared by centrifugation at 30,000 g for 1 hour, and 10 
mM MgCl2 was added to the supernatant to quench the EDTA prior to mixing with Ni-
NTA resin. 
 The supernatant was incubated with Ni-NTA resin (either Agarose or Superflow, 
Qiagen, Valencia, CA) for 30 minutes. The media was packed into a gravity column, and 
washed with 6 CVs of buffer B containing 30 mM imidazole, 0.05% ß-DDM, and 0.01% 
E. coli polar lipids. The bound MsbA was eluted with 4 CVs of buffer B containing 250 
mM imidazole, 0.05% ß-DDM, and 0.01% E. coli polar lipids. The fractions containing 
MsbA were pooled and supplemented with 2 mM EDTA and 2 mM DTT, concentrated, 
and incubated with the TEV protease overnight to remove the C-terminal His6-tag. The 
His6-tag removed MsbA was further purified by an anion exchange column (Q-sepharose 
fastflow, GE healthcare, Piscataway, NJ). Fractions containing MsbA were pooled, 
concentrated, and purified by a size exclusion chromatography column (Superdex 200, 
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GE Healthcare, Piscataway, NJ). The final MsbA in buffer (10 mM HEPES, pH = 7.0, 
100 mM NaCl, 1 mM EDTA, 0.05% α-DDM, and 0.01% E. coli polar lipids) was 
concentrated to 6~8 mg/mL using a 100 kDa Amicon ultrafiltration device and stored in 
small aliquots at -80°C. 
4.2.3 Lantibiotic transporters, HalT and LanT, expression and purification 
 The genes for HalT and LanT were amplified from the genomic DNAs for B. 
halodurans and B. licheniformis, respectively, purchased from American Type Culture 
Collection (ATCC, Manassas, VA). Both HalT and LanT were sub-cloned using NdeI 
and XhoI into a modified pET24a (which contains a TEV cleavable site, a flag tag, and a 
His10-tag on the C-terminal end) for protein expression. Like other proteins, these 
lantibiotic transporters were expressed in C43 (DE3) cells grown at 25 ºC in TB. At the 
OD600 ~ 0.5, protein expression was induced with 0.5 mM IPTG, and the cell growth was 
continued at 25 ºC for 16 hours. Cells were harvested by centrifugation and purified 
based on the protocol used for MsbA (see section 4.2.2).  
 Cell pellets were washed and resuspended in buffer A. After cell lysis by 
sonication, unbroken cells were removed by low speed centrifugation at 5000 g for 10 
min and the membrane fractions were collected by ultracentrifugation at 27000 rpm 
(SW28 rotor, Beckman Courter) for 65 minutes. The proteins were extracted with 1.0% 
ß-DDM and 0.01% Soy PC (Avanti Polar Lipids, Alabaster, AL) in buffer B containing 
0.01% E. coli polar lipids for overnight at 4 ºC with gentle shaking. After a second 
ultracentrifugation at 27000 rpm for 60 minutes, the cleared supernatants were loaded 
onto a Ni-NTA resin equilibrated with butter B containing 30 mM imidazole, 0.05% ß-
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DDM, and 0.01% E. coli polar lipids. The resin was washed with 10 CVs buffer B 
containing 30 mM imidazole, 0.05% ß-DDM, and 0.01% E. coli polar lipids and the 
bound proteins were eluted with buffer B containing 250 mM imidazole, 0.05% ß-DDM, 
and 0.01% E. coli polar lipids. Fractions containing the proteins were pooled and 




4.3  Results and Discussions 
4.3.1 Double E131Q/E159Q-BtuCD mutant 
 The double E131Q/E159Q-BtuCD mutant was expressed and purified as 
described in Chapter 2. The size-exclusion profile showed a well resolved single peak 
and the final concentrated (~14 mg/mL) protein was as stable as the wild-type BtuCD. 
After reconstituting into nanodiscs, the ATPase activity of the E131Q/E159Q-BtuCD 
mutant was determined by the Malachite-Green assay and the results are shown in Figure 
4.3B. The assays were performed at 37 ºC in a water bath using 60~100 nM BtuCD in 
nanodiscs with 2 mM ATP and 5 mM MgCl2. The hydrolysis rates were analyzed via 
linear regression using a Prism 5.0a (GraphPad Software, La Jolla, CA). The 
E131Q/E159Q-BtuCD could not hydrolyze ATP (the corresponding rates for the wild-
type BtuCD are shown in 4.3A). 
 
Figure 4.3 ATPase activity of double E131Q/E159Q-BtuCD mutant. (A) ATPase rates of wild-type BtuCD. 




 A quick crystallization screening was carried out using the sitting-drop vapor-
diffusion method with equal volumes of protein and screening solution (0.5 µL each). 
Two plates were setup using a Mosquito (TTP LabTech, Cambridge, MA) with 
commercially available 96 HT membrane protein screens (Memstart & Memsys, 
Molecular Dimensions, Apopka, FL). The plates were incubated at two temperatures, 4 
and 20 ºC, and inspected routinely for any sign of protein nucleation. In the plate 
incubated at 20 ºC, needle-shaped crystals appeared under two conditions (conditions 
F12: 100 mM CAPSO, pH 9.5, 100 mM NaCl, 100 mM MgCl2, 30% v/v PEG400, and 
H12: 100 mM CAPSO, pH 9.5, 100 mM NaCl, 100 mM MgCl2, and 12% w/v PEG4000) 
after two days, however, these crystals degraded quickly. About 2 weeks later, 
orthorhombic crystals appeared on the plate incubated at 4ºC in a drop in 100 mM 
HEPES, pH 7.5, 2.0 M ammonium sulfate, and 2.0% PEG400 and continued growing 
until the longest dimension was ~200 µm after 3 weeks. A number of replication drops 
were setup using the original screening solution and also a home-prepared solution, but 
crystals grew in drops containing only the commercial solution. 
 With Farhad Forouhar’s assistant, four crystals from the initial and the replicate 
plates were mounted and sent out for screening at the National Synchrotron Light Source 
(NSLS). One crystal from the initial plate diffracted to a resolution of 5 Å, on which a 
native data set was collected on the beamline X4C of NSLS at the Brookhaven National 
Laboratory. After processing the diffraction images using HKL package, the structure 
was determined by the molecular replacement method using the previous BtuCD (PDB 
ID: 1L7V) as a search model. The crystal belonged to the orthorhombic space group 
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C2221, with unit-cell parameters a = 180.742, b = 324.689, c = 118.877Å as shown in 
Table 4.1. 
 Although we need to grow better diffracting-quality crystals that diffract x-rays to 
higher resolutions so as to draw clear conclusions about the structure, a quick inspection 
of the Fo-Fc difference map reveals no electron density at the dimer interface for the 
cofactor ATP. Instead, the presence of two small electron densities at the interface 
suggests that two sulfate molecules from the precipitation cocktail are possibly bound at 
the nucleotide binding sites. 
Table 4.1 Crystallographic refinement statistics of E131Q/E159Q-BtuCD 
Data collection 
Space group: C2221 
Cell dimensions (Å) 
a=180.742 b=324.689 c=118.877 





Bond length r.m.s.d. (Å): 0.0069 
Bond angle r.m.s.d. (º): 1.271 





Figure 4.4 Diffraction image of the double E131Q/E159Q-BtuCD mutant. (A) Diffraction image of a crystal 
grown in a well containing 100 mM HEPES, pH 7.5, 4.0% PEG 400, and 2.0 M Ammonium sulfate. (B) The 
Ribbon diagram of the crystal structure (cyan and blue for one protomer and yellow and orange for another) 
and 2Fo-Fc electron density map contoured at 1 σ in a green mesh are shown. 
 
4.3.2 E. coli MsbA crystal optimization 
4.3.2.1 Epitope engineering to enhance crystal lattice formation 
 Protein folding and protein crystallization are both entropy-driven processes. A 
recent study from the Hunt lab reinforces the idea that the major driving force for protein 
crystallization is the entropy of the surface-exposed side chains [40]. Since the solvent-
exposed high-entropy residues interfere with the crystal lattice formation, replacing these 
side chains with ones with low entropy would enhance the crystal packing contacts. 
Recent studies suggest that the entropy reduction approach successfully led to 
crystallization of several proteins that had previously resisted crystallization [41,42]. 
Furthermore, data-mining analysis on a set of proteins that have gone through the 
Northeastern Structural Genomics Consortium (NESGC) pipeline suggested that glycine, 
phenylalanine, and alanine favor crystallization [40].  
[CHAPTER)4)–)CRYSTALLIZATION)OF)ABC)TRANSPORTERS]! 126 
 
 As a part of an undergraduate course, a number of MsbA mutants were generated 
and tested for their crystallization propensities. MsbA readily crystallizes but most 
crystals diffracted to only low resolutions. Therefore, it was a perfect example to test a 
surface entropy reduction approach. The undergraduate students in the project lab have 
successfully generated a number of surface mutants as shown in Table 4.1.  
Table 4.2 List of MsbA mutants for a surface entropy reduction analysis 
Single cluster mutant Double cluster mutants 
1.  KT58-59AA 8.  KT58-59AA & Q166G 
2.  IxxxI72-76GxxG 9.  KT58-59AA & EQIE448-451AAIA 
3.  Q166G 10. K58A & MD276-277AG 
4.  K232F 11. K232F & MD276-277AG 
5.  MD276-277AG 12. MD276-277AG & EQIE448-451AAIA 
6.  EQIE448-451AAIA 13. MD276-277AG & K465F 
7.  K465F  
 
 All mutants were expressed and purified in the same way as described previously 
for wild-type MsbA in the methods section. Some of the mutants were clearly less stable 
and not suitable for crystallization trials. The mono-dispersity and oligomerization states 
of purified mutant proteins were analyzed by a size exclusion chromatography (Shodex 
802.5 column, Showa Denko, New York, NY) combined with Static Light Scattering 
(Wyatt Technology, Santa Barbara, CA) to accurately calculate the molecular weights of 
the proteins. Four of the seven single cluster mutants (#1, 4, 5, 6) and all the double 




Figure 4.5 Improved crystallization propensity of an epitope engineered MsbA. (A) Schematic summary of 
the results from an initial crystallization screen at 20 ºC. The MD-to-AG-MsbA mutant yielded 5 excellent hits, 
and 23 total hits whereas the wild-type yielded only 1 and 8, respectively. Pictures were taken from two wells 
containing the same crystallization cocktail for the MD-to-AG-MsbA (B) and the wild-type MsbA (C).  
 
 Stable mutants were tested for their crystallization propensity using a commercial 
96-well high throughput screen (Memstart & Memsys, Molecular Dimensions, Apopka, 
FL). A number of them crystallized better than the wild-type MsbA, and MD276-277AG-
MsbA was one of the more promising ones. The result of the initial crystallization screen 
for MD276-277AG-MsbA is shown in Figure 4.5A. MD267-277AG residue pair was 
selected based on the sequence comparison between MsbA and a remote homolog, 
Sav1866, the structure of which showed that these residues form part of a crystal packing 
contact. The mutant yielded 5 excellent hits and 23 total hits, whereas the wild-type had 1 
excellent hit and 8 total hits (microscope images of the two wells containing the same 
precipitation cocktail for both MD-to-AG and the wild-type are shown in Figure 4.5B-C). 
Since this epitope engineered mutant crystallized better than the wild-type, the 




4.3.2.2 Detergent optimization 
 One of the most effective strategies of improving the diffraction quality of a 
membrane protein is to crystalize the protein using a short-chain detergent, for they form 
smaller micelles than those of long-chain detergents around a membrane protein. This 
approach provides a larger hydrophilic surface area for crystal packing interactions 
thereby making it easier to form diffraction-quality crystals.  
 Dodecylmaltoside (ß-DDM) is a mild neutral detergent most commonly used 
when extracting membrane proteins from the phospholipid bilayer. However, the 
detergent forms large micelles and prevents tight crystal contacts. Because of this, 
screenings for a suitable detergent are routinely performed to find an alternative detergent 
that might expose more surface area for lattice contacts. With this approach, a bacterial 
homologue (Haemophilus influenzae) of SLAC1 was determined to 1.2Å resolution upon 
crystallization in OG [43].  
 MsbA was extracted from the membrane bilayer using ß-DDM and also 
crystallized in the same detergent. Therefore, in an effort to find alternative short-chain 
detergents, a detergent screening was performed for MsbA with 12 different commonly 
used detergents. A small volume of MsbA in DDM was injected onto a size-exclusion 
column equilibrated with a new detergent at ~2X of the detergent CMC. Screening was 
done at the New York Consortium on Membrane Protein Structure (NYCOMPS) as 
described [44]. Figure 4.6A shows the screening results demonstrating that MsbA was 
stable in a number of detergents including DM and C12E8. Unfortunately, MsbA was 
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unstable in detergents that form small micelles (e.g., n-Octyl-ß-D-glucoside, OG, and n-
Octyl-ß-D-maltoside, OM, Anatrace, Maumee, OH). 
 
Figure 4.6 Detergent screening by a size-exclusion chromatography. (A) Twelve most commonly used 
detergents were tested for the stability of MsbA. The final detergent concentrations are 2X CMC. The protein 
was purified by SEC column and the corresponding chromatograms are shown. (B) Relative sizes of 
detergent micelles around Yeast mitochondrial ADP/ATP carriers: from the smallest micelles with 
octylmaltoside (red) to the largest tridecylmaltoside (purple). The Stokes radii were determined by size-
exclusion chromatography [45,46]. 
 
 MsbA was also stable in LDAO (not among the 12 detergents tested), but MsbA 
purified in LDAO failed to crystallize. Two other detergents, DM and C12E8, were tested, 
which did not yield any crystals. 
4.3.2.3 Crystal grown by micro-batch method diffracted better 
 Crystallization conditions for the MD276-2770-AG-MsbA in DDM were further 
optimized. Crystals grown by the microbatch method under paraffin oil generally looked 
and diffracted better. Addition of 0.1% LDAO, identified through detergent additive 
screening, further improved the quality of crystals as shown in Figure 4.7(A-L). A 
number of different crystal forms appeared, several f which diffracted to ~6 Å as shown 
in Figure 4.7(I-L). However, all these efforts have not thus far yielded diffraction quality 




Figure 4.7 Example crystal images and diffraction patterns of MD-to-AG MsbA mutant grown under oil. (A-H) 
Crystals were grown using a micro batch method under paraffin oil. (I-L) Representative diffraction patterns. 
 
4.3.3 Buffer optimization for lantibiotic transporters, HalT and LanT 
 Both HalT and LanT could be expressed in large amounts in E. coli C43 cells. 
The cell growth was not hampered by the expression of these heterologous membrane 
proteins (the final cell density reached an OD600 of ~14). Analyses of the elution fractions 
from Ni-NTA chromatography are shown in Figure 4.8 (A-B for HanT and LalT, 
respectively). As shown in corresponding bands, both proteins were well expressed and 
reasonably pure proteins could be obtained from a one step Ni-NTA affinity column. 
However, both proteins were extremely unstable thereafter. Since they behaved in an 
almost identical manner, they will hereinafter be called HalT. 
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 The stability of HalT (or LanT) greatly decreased when imidazole was removed 
by either dialysis or desalting, and the protein readily formed irreversible aggregates. The 
buffer optimization was therefore conducted prior to crystallization trials. 
 
Figure 4.8 Ni-NTA purified HalT and LanT. (A-B) Expression levels for both proteins were very high and the 
elution fractions indicated with red rectangles were pooled and concentrated for further analysis. (C) ATPase 
activity of HalT in the absence and presence of its cognate substrates. The correctly modified substrate 
(M2HalA2) stimulated the activity the most. Both processed and un-processed substrates were obtained 
from the van der Donk lab (Dept. of Chemistry, University of Illinois). 
 
 The stability of the protein was assessed either by dynamic light scattering 
measurements (DLS, Wyatt Technology, Santa Barbara, CA) or by repeated rounds of 
buffer exchange using an Amicon micro-concentrator (EMD Millipore, Billerica, MA). 
Various buffers with different pHs, and a wide range of NaCl and glycerol concentrations 
and other stabilizing components including arginine, glutamate, and aspartate were tested 
either alone or in combination to improve protein stability. The results from the DLS 
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measurements were analyzed using Dynamics (Wyatt Technology, Santa Barbara, CA), 
and the buffer exchange results were analyzed by SDS-PAGE. 
 
Figure 4.9 Buffer optimization to improve the stability of HalT. (A) HalT stability test in different buffer 
conditions by Dynamic Light Scattering. (B) HalT was purified by size-exclusion chromatography in 
conditions identified through a series of screenings, and the final concentrated sample was analyzed by 
SDS-PAGE. Crystallization trials were set up using the concentrated HalT from (B) with Memstart & Memsys 
from Molecular Dimensions. (C-D) Two pictures show spherulite looking crystals. 
 
 A number of conditions improved the stability of HalT (and LanT) at the range of 
protein concentrations tested (0.5~2.0 mg/mL). For example, 20% glycerol and 300~500 
mM NaCl improved the stability of the protein. Added lipids also increased solubility. 
However, even after extensive buffer optimization, the protein was still unstable and 
aggregated in a concentration-dependent manner. Since crystallization requires large 
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amount of proteins at high concentrations, carrying out crystallization trials with the 
aggregation-prone HalT was not promising and did not yield any crystals. 
Attempts were made to generate mutant HalT and also LanT by removing the N-terminal 






4.4 Conclusions and Perspectives 
 Over the last 20 years, the field of structural biology has made tremendous 
accomplishments, determining ~80,000 protein structures, and the numbers continue to 
grow (Protein Data Bank [PDB], www.rcsb.org). However, membrane protein structures 
represents only a small fraction (< 2.0%) in the PDB, even though almost one third of the 
genes in any given sequenced genome encodes for integral membrane proteins. While the 
number of membrane protein structures in the PBD is steadily increasing, determining the 
structure of membrane proteins still remains challenging due to three major obstacles: 
expression, purification, and crystallization.  
 ABC transporters tested in this chapter did not have the first problem. They all 
expressed and purified in large quantities. With the possible exception of BtuCD, they all 
have problem(s) in at least one of the last two steps. In the case of MsbA, the challenge 
lies in the crystallization stage. As shown above, MsbA crystallizes quite well, but the 
quality of the crystals needs substantial improvement. Optimization of the crystal growth 
conditions for MsbA will be revisited sometime in the near future. 
 Although the lantibiotic transporters are very interesting ABC transporters, these 
proteins were unstable once removed from their physiological membrane environments. 
To overcome this obstacle, it would be worthwhile to test other close homologs for 
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Conclusions and future directions 
 
 Proteins in solution are dynamic macromolecules constantly moving and 
sampling all possible conformational states. The E. coli vitamin B12 transporter BtuCD is 
no exception. Therefore, a complete understanding of the transport mechanism of the 
BtuCD can only be possible when the dynamic properties are combined with the static 
structures. In this thesis, I presented the results of real-time observation of substrate 
transport through the transporter via ensemble FRET measurements and of the 
conformational dynamics of the TMDs using smFRET measurements. 
 Reconstituting BtuCD (or membrane proteins) into a small disk of phospholipid 
bilayer (“nanodiscs”) has enabled the use of biochemical and biophysical techniques 
normally reserved for soluble proteins to be applied to membrane proteins in isolation. E. 
coli lipid extracts were used in reconstitution, and BtuCD in nanodiscs was very stable 
and retained its physiological activity. 
 BtuCD reconstituted into nanodiscs exhibited native-like activity (compared to 
the ones reconstituted into proteoliposmes). As shown previously by Ramos et al. [1] 
isolated transporters were capable of translocating their substrate even in the absence of 
nucleotide although at slower rate, which supports the idea that these transporters are 
intrinsically dynamic macromolecules sampling multiple conformations [2-4]. ATP 
binding and hydrolysis greatly increased the rate of substrate transport, and the 
conformational changes on either NBDs or TMDs were transduced to the other side 
through the coupling helices. 
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 Single-molecule fluorescence resonance energy transfer (smFRET) is a powerful 
technique that enables monitoring of the dynamics of a single macromolecule in real time 
[5-7]. Using smFRET methods, we monitored conformational dynamics on the TMDs of 
BtuCD during the transport cycle. The results from smFRET measurements revealed the 
TMD conformational dynamics in unprecedented details: apo-BtuCD sampled multiple 
conformations even in the absence of extra stimuli, and BtuF binding induced 
conformational changes on the TMDs. The cytoplasmic end of TM9 closed upon binding 
to BtuF whereas the periplasmic end of TM9 opened. In the absence of stimuli, Q111 on 
ECL-2 exhibited intrinsically dynamic nature of the transporter sampling conformations 
that are observed in the structures of BtuCD and BtuCD-F complex (PDBs: 1L7V and 
2QI9, respectively). 
 The ATP-hydrolysis deficient mutant (E159Q-BtuCD) was studied by smFRET, 
and, although more data should be analyzed to draw concrete conclusions, the results 
indicated that ATP binding and NBDs dimerization seemed to be reversing the action of 
BtuF binding to BtuCD and inducing wide opening of the cytoplasmic end of TM9 
(BtuC-V274). Efforts are now underway to collect more data using E159Q-BtuCD 
mutant with fluorescent probes in other locations to characterize the conformational 
states upon binding to ATP molecules. 
5.1 Analysis of conformational transition rates 
 Single-molecule FRET time trajectories can be quite noisy, and more rigorous 
analyses of the data are done employing a statistical approach using a Hidden Markov 
model (HMM) [8,9]. Therefore, all FRET traces were subjected to a global non-biased 
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analysis using a HMM implemented in an analysis program called hFRET (developed by 
Dr. Jan-Willem van de Meent, a postdoctoral fellow in the Gonzalez lab). This analysis 
identifies the most probable conformational states within each smFRET trace and the 
path through those states. The resulting idealized smFRET traces contained not only the 
probable conformational states but also information on the kinetics of their 
interconversion. 
 From these idealized smFRET time trajectories, the kinetic transition rates 
between different conformational states will be calculated in the future. For each state of 
the transport cycle (the apo-resting, BtuF-bound, and ATP-bound states), the transition 
rates between conformational states from fluorescent probes at various sites will be 
compared to see if a transporter exhibits any concerted global conformational dynamics 
or whether each region exhibits conformational dynamics that are independent from other 
regions. The results from this analysis will provide an opportunity to rule out changes in 
mechanism and dynamics due to the incorporation of the fluorophore probes. 
 Canonicalization of the ABC signature motif in the NBDs of BtuCD (from 
LSGGE to LSGGQ, E131Q-BtuCD) generated a mutant that was thermodynamically 
more efficient compared to wild-type BtuCD. In follow-up research, it will be interesting 
to determine whether the conformational kinetics of this mutant has been altered. 
Therefore, E131Q-BtuCD mutant will be studied by smFRET measurements and its 
kinetic transition rates will be compared to those of wild-type BtuCD. 
5.2 Molecular dynamics simulations 
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 Using molecular dynamics simulations, the observed conformational states in the 
TMDs of BtuCD will be assessed and compared. With the improvements in both 
computing power and simulation methods, molecular dynamics simulations are now able 
to study protein dynamics at physiologically relevant time scales (from 1 µs and longer). 
Because molecular simulations can reveal not only the conformational states but also all 
inter-connected underlying local atomic interactions that collectively create the protein 
motions, it will help us better understand the protein dynamics and conformational 
changes. The lab of Dr. Tajkhorshid at the Universtity of Illinois at Urbana-Champaign 
(UIUC) has done extensive studies on the mechanisms of energy coupling and protein 
conformational changes in a number of membrane proteins including recent work on the 
conformational coupling between the NBDs and the TMDs in the E. coli maltose 
transporter, MalFGK2 [10]. In an effort to see whether the TMD conformational states 
observed during the transport cycle by smFRET measurements can also be revealed by 
molecular dynamics simulations, we will be collaborating in the future with Dr. Emad 
Tajkhorshid’s lab at UIUC to perform molecular dynamics simulation on BtuCD. 
5.3 Three-color smFRET experiments 
 When carrying out smFRET experiments using the BtuCD-F complex, pre-
incubated complexes were diluted only shortly before delivering them to the sample 
chamber to prevent protein dissociation. It was, however, possible that some percentage 
of BtuF might have dissociated from BtuCD. Since the fluorescent probes were 
introduced to BtuCD it was not possible to differentiate the fluorescence signals from 
BtuCD-F complex vs. BtuCD alone. Therefore, a three-color experiment [5,11,12] will be 
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carried out using BtuF labeled with a third fluorescent probe (e.g., Alexa Fluor 488) to 
directly monitor the presence of both BtuCD and BtuF. Alexa Flour 488 does not 
interfere with the FRET between Cy3 and Cy5, and will be monitored only at the 
beginning to use it as a molecular indicator to distinguish BtuF-bound from BtuF-free 
complexes. By selecting and analyzing single-molecule traces that show all three 
fluorescence signals, we should be able to get cleaner results. 
 In a parallel experiment, a saturation binding analysis will be performed with 
unlabeled BtuF. Unlabeled BtuF will be titrated onto the channels with pre-immobilized 
BtuCD, and the corresponding conformational distributions will be analyzed at varying 
free BtuF concentration. 
5.4 Crystal optimization to capture ATP-bound conformation 
 The structure of ATP-bound BtuCD-F complex should unambiguously show the 
mechanical transition state that has been elusive so far due to the dynamic nature of the 
transporter. In fact, no type II importer structure has been successfully crystalized in a 
nucleotide-bound transition state. Recently, Korkhov et al. solved yet another BtuCD-F 
complex structure using an ATP hydrolysis deficient mutant (E159Q-BtuCD) so as to 
capture ATP-bound transition state [13]. Yet the resulting crystal structure failed to retain 
ATP molecules [13] although this mutant is perfectly capable of binding ATP molecules, 
as demonstrated in chapters 2 and 3 of this thesis. The conformation observed in this 
recent crystal structure reaffirms the flexible nature of the transporter and how difficult it 




 As I have shown in Chapter 2 in this thesis, the E131Q-BtuCD mutant is 
thermodynamically more efficient compared to wild-type BtuCD. Furthermore, in an 
effort to make a mutant that is capable of trapping ATP molecules at the dimer interface 
thereby capturing the transition state, a double E131Q/E159Q-BtuCD mutant was 
generated (a canonicalized-ATP hydrolysis-deficient mutant). A quick crystallization 
screening with BtuCD alone in the presence of 20 mM Na-ATP yielded crystals that 
diffracted to ~5 Å, and the structure was solved by molecular replacement using the 
previous apo-BtuCD (PDB: 1L7V) as a search model. The resulting structure was almost 
indistinguishable from the previous and no bound-nucleotide was observed. 
 We will, therefore, pursue the optimization of the crystal growth conditions for 
this mutant to obtain crystals that diffract to a higher resolution and also to trap ATP 
molecules at the dimer interface. Both BtuCD alone and the BtuCD-F complex will be 
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